Endothelin家族基因SNPs及单体型分子标记与长沙汉族人群脑出血的关系研究
|
摘要
背景与目的：脑出血(Cerebral hemorrhage, CH)作为脑血管疾病的主要类型之一,其病死率、致残率高,严重危害人类健康。对脑出血病因的研究成为脑血管防治上的重要课题。目前分子遗传学研究认为,脑出血和其他复杂性疾病一样,是由于多个易感的微效基因相互作用,并与环境因素共同作用的结果。因此,对脑出血候选基因单核苷酸多态性(single nucleotide polymorphisms, SNPs)的研究将有助于阐明脑出血的遗传本质,为脑出血易感患者的早期防治提供依据。高血压目前公认是脑出血的独立危险因素,动脉粥样硬化也是脑出血的危险因素之一。长沙是世界脑出血高发区之一,受国家“七五”“八五”、“九五”攻关课题资助,我们既往在长沙地区的多年临床流行病学研究和分子遗传学研究表明,高血压和动脉粥样硬化均是是长沙汉族人群脑出血发病的危险因素,其中高血压和与之有关的遗传因素更是起到至关重要的作用。而内皮素家族(Endothelin Family)及其内皮素家族基因(human endothelin family genes)目前认为与高血压、动脉硬化均有密切关系,可能导致高血压的发生及动脉粥样硬化,增加脑出血的发病风险。迄今,有关内皮素家族基因合成调节途径相关基因与脑出血的关系国内外未见报道。本研究旨在探讨该途径中内皮素-1基因(EDN1)、内皮素受体A基因(EDNRA)、内皮素受体B基因(EDNRB)、内皮素转换酶基因(ECE1)的SNPs和单倍型(haplotype)与长沙地区汉族人群脑出血的关系。
方法：收集2006年1月至2009年12月在湘雅医院神经内科就诊的脑出血患者及部分家属的临床资料和外周血标本,所有病例均经CT和／或MRI确诊。研究对象均来自长沙地区汉族人群,包括：1.有家族聚集现象的脑出血家系组(cerebral hemorrhage with family history, CHFH):共65个家系,包括家系成员281例,男178例,女103例,分为以下亚组：①家系组脑出血患者组：65例,男46例,女19例,平均年龄(52.42±11.50)岁。②Ⅰ级亲属组(CHFH-I):133例(包括患者父母,子女及同胞兄弟姐妹),男69例,女64例,平均年龄(39.52±14.17)岁。③Ⅱ级亲属组(CHFH-II):36例,男26例,女10例,平均年龄(31.93±12.21)岁。④Ⅲ级亲属组(CHFH-II):10例,男7例,女3例,平均年龄(32.65±12.95)岁。⑤健康无血缘关系亲属(unaffected non-blood relatives)共37例,男30例,女7,平均年龄(47.68±7.64)岁。来自以上有家族聚集现象脑出血家系中与先证者无血缘关系的家庭成员,为先证者及其Ⅰ、Ⅱ、Ⅲ级亲属的配偶。2.散发性脑出血(Sporadic cerebral hemorrhage, SCH)组：195例,男133例,女62例,平均年龄(58.40±11.21)岁。3.正常对照(control)组：男75例,女41例,平均年龄(54.97±10.41)岁。
血压的测量：对所有受试对象的血压进行测量。根据2004年《中国高血压防治指南》公布的诊断标准,按收缩压≥140mmHg,和／或舒张压≥90mmHg诊断为高血压。
血脂的检测：采用氧化酶法测定甘油三脂(Triglyceride, TG)、总胆固醇(Total cholesterol,TC);测定高密度脂蛋白(High density lipoprotein, HDL)先用沉淀剂沉淀,再用氧化酶法测定上清液中的胆固醇；低密度脂蛋白(Low density lipoprotein, LDL)由Friedwald公式：LDL=(CHO-HDL)-TG/5计算。
基因分型：利用多重单碱基延伸SNP分型技术(Multiplex Snapshot)与DNA测序结合相互印证的方法检测所有研究对象内皮素-1合成调节途径4个基因10个SNPs位点多态性,包括：内皮素-1基因的rs1800541、rs2070699、rs5370,内皮素受体A基因rs1801708、rs5333、rs5335,内皮素受体B基因的rs3818416、rs5351,内皮素转化酶-1基因的rs2212528、rs213045。
统计：采用SPSS软件对散发性脑出血与正常对照组进行统计分析,两组间基因型与等位基因频率的差异用x2检验,不同基因型亚组间血压水平比较采用ANOVA方差分析。采用FBAT软件对有家族聚集现象脑出血家系的内皮素家族基因的多态性位点及其构建的单体型进行传递不平衡检验(Transmission disequilibrium test, TDT)。
结果：
1.基因多态性分布特征：长沙地区汉族人群存在EDN-1基因rs1800541、rs2070699、rs5370位点多态性,EDNRA基因rs1801708、rs5333、rs5335位点多态性,EDNRB基因rs3818416、rs5351位点多态性和ECE-1基因rs212528, rs213045多态性。这些多态位点基因型和等位基因分布频率均与世界其他地区人群的基因多态性分布存在不同程度种族差异性。
2.散发性脑出血与正常对照人群的病例-对照研究(case-control study)结果：①散发性脑出血组与对照组EDNRA基因rs1801708、rs5333各基因型及等位基因频率比较有统计学意义(p<0.05)；②散发性脑出血组与对照组EDNRB基因rs5351等位基因频率比较差异有统计学意义,散发组脑出血的最低等位基因G的频率(minor allele frequency, MAF)明显低于对照组(x 2=4.83,P<0.05)。③散发性脑出血组EDN-1基因rs1800541、rs2070699、rs5370多态各基因型及等位基因频率分布与对照组比较差异无统计学意义(P>0.05)。④散发性脑出血组与对照组ECE-1基因rs212528,rs213045多态各基因型及等位基因频率分布与对照组比较差异无统计学意义(P>0.05)。
3.有家族聚集现象脑出血家系的FBAT研究结果：①TDT分析发现EDNRA基因rs5335多态性位点的等位基因C向后代发生了过度传递现象(P<0.05)。EDNRA基因rs1801708、rs5333、rs5335多态位点构成的单体型G-T-C存在过度传递现象(P<0.05)；其中由EDNRA基因rs1801708和rs5335多态位点构成的单体型G-C、由EDNRA基因rs5333和rs5335多态位点构成的单体型T-C也存在过度传递现象(P<0.05)。③TDT分析未发现EDN-1基因rs1800541、rs2070699、rs5370多态性位点的等位基因存在传递不平衡现象(P>0.05),这三个位点构建单体型后进行TDT分析也未发现单个特异单体型存在过度传递现象(P>0.05)。④TDT分析未发现EDNRB基因rs3818416、rs5351多态位点从亲代到患病子代的过度传递现象(P>0.05),对他们构建的单体型分析也未发现过度传递现象(P>O.05)。⑤TDT分析未发现ECE-1基因rs212528,rs213045位点多态位点从亲代到患病子代的过度传递现象(P>0.05),对他们进行单体型构建后TDT分析未发现单个特异单体型存在过度传递现象(P>0.05)。
4.长沙汉族人群内皮素家族基因多态性对血压水平的影响：①散发性脑出血组EDNRA基因rs5335的GG基因型亚组与GC/CC基因型亚组间舒张压和平均动脉压之间存在显著性差异(P<0.05)。②散发性脑出血组ECE-1基因rs212528的AA与AG/GG基因型亚组之间的收缩压水平存在显著性差异(P<0.05)。③散发性脑出血组及对照组EDN-1基因rs1800541的TT基因型亚组与GT/GG基因型亚组之间、rs2070699位点GG基因型亚组与GT/TT基因型亚组之间、rs5370位点的GG基因型亚组与GT/TT基因型亚组之间的收缩压、舒张压和平均动脉压水平均无显著性差异(P>0.05)。④散发性脑出血组和对照组EDNRB基因rs5351各多态位点的基因型亚组之间的收缩压、舒张压和平均动脉压水平无显著性差异(P>0.05)。
结论：
1. EDNRA基因rs1801708、rs5333、rs5335, EDNRB基因rs5351位点多态位点可能与长沙汉族人群脑出血发病有关。
2. EDNRA基因rs1801708、rs5333、rs5335多态位点构成的单体型G-T-C、由EDNRA基因rs1801708和rs5335多态位点构成的单体型G-C、由EDNRA基因rs5333和rs5335多态位点构成的单体型T-C可能是长沙汉族人群脑出血的遗传易感因素之一。
3. EDNRA基因rs5335、ECE-1基因rs212528多态位点可能与长沙汉族脑出血易感人群的血压水平有关,其中EDNRA基因rs5335可能通过影响血压而增加了长沙汉族人群脑出血的发病风险。
4.EDN-1基因rs1800541、rs2070699、rs5370, EDNRB基因rs3818416, ECE-1基因rs213045位点多态性可能与长沙汉族人群脑出血和血压水平无关；ECE-1基因rs212528位点与与长沙汉族脑出血易感人群的血压水平有关但与脑出血的易感性无关。
Background and objective:
Cerebrovascular disease is the second commonest cause of death and leading cause of adult disability worldwide, of which cerebral hemorrhage (CH) represents a main subtype with high morbidity and disability. The etiology of CH is increasingly becoming an important concern in prevention and cure of cerebrovascular disease. Current studies on the clinical and molecular genetics stress this heterogeneous disease caused by the interactions among many minor genes and environmental factors. The study on candidate genes SNPs(single nucleotide polymorphisms) about CH will help us to understand the molecular nature of this disease and suggest a theory for prevention and treatment of CH.
Hypertension is an independent risk factor of CH and atherosclerosis is an important risk factor of CH, too. Our clinical epidemiology study on CH in the past dozen years has verified the conclusion that hypertension and atherosclerosis are risk factors related to CH, in which hypertension is the most important one. The human endothelin family gene is thought to play an important role in the development of atherosclerosis, hypertension and may increase the risk of CH. Up to now, there are few studies on the relationship between the polymorphism of Endothelin family gene and CH. Identification of gene polymorphisms of endothelins that confer susceptibility to CH and the development of genetic risk diagnosis systems may contribute to the personalized prevention of these conditions. Our aim is to investigate the correlations of the polymorphism of Endothelin family gene with CH in the Changsha Han ethnic group.
Methods:
All subjects came from Changsha Han population which were composed of 3 groups:(1) 281 members of 65 family with CH aggregation, including:①65 CH patients with family history:46 men and 19 women, averagely aged 52.42±11.50 years;②133 first-degree relatives:69 men and 64 women, averagely aged 39.52±14.17 years;③36 second-degree relatives:26 men and 10 women, averagely aged 31.93±12.21 years;④10 third-degree relatives:7 men and 3 women, averagely aged 32.65±12.95 years;⑤37 relatives with no kinship with proband:30 men and 7 women, averagely aged 47.68±7.64 years, who are spouses of the proband or the first-degree and second-degree relatives. (2)Sporadic cerebral hemorrhage (SCH) group:195 patients with sporadic cerebral hemorrhage,133 men and 62 women, averagely aged 58.40±11.21 years. (3) Control group:116 healthy controls,41 men and 75 women, averagely aged 54.97±10.41 years.
The measures of blood pressure:The blood pressure of every subject was measured and the hypertension was diagnosed according 2005 guidelines for The prevention and treatment of hypertension in China.
Serum lipid levels were tested:Total cholesterol (TC), High density lipoprotein (HDL) and triglycerides (TG) were measured by standard enzymatic methods. LDL cholesterol levels were calculated with the Friedewald formula (LDL=TC-HDL-TG/5).
Multiplex SNaPshot genotyping analysis and DNA sequencing were used to detect 10 SNPs in 4 genes associated with endogenous endothelins synthesis of some subjects, including:rs 1800541、rs2070699、rs5370 of endthelin-1 gene, rs1801708、rs5333、rs5335 of endothelin receptor A gene, rs3818416、rs5351 of endothelin receptor B gene and rs2212528、rs213045 of Endothelin-converting enzyme 1 gene.
The frequencies of the alleles and genotypes between the SCH group and control group were analyzed byχ2 analysis, and blood pressure levels were compared among genotypes by ANOVA using SPSS. The SNP and haplotype transmissions of the CH pedigrees were analyzed by transmission disequilibrium test (TDT) using FBAT computer program. Results:
1. The distribution of Endothelin family gene polymorphism in Changsha Hans population:There are EDN-1gene rs 1800541、rs2070699、rs5370 polymorphisms, EDNRA gene rs 1801708、rs5333、rs5335 polymorphisms, EDNRB gene rs3818416、rs5351 polymorphisms and ECE-1 gene rs3818416、rs5351 polymorphisms in Changsha Han population. These gene polymorphisms in Changsha Han population revealed obvious racial difference comparing with those of other regions in the world in different extents.
2. The results of the case-control study in SCH and normal controls were as follows:①There is significant difference of genotype and allele frequencies of EDNRA gene rs180178、rs5333 between SCH group and control group(p<0.05).②The frequencies of G allele (MAF) of EDNRB gene rs5351 was significantly lower in SCH group than those in control group (p< 0.05).③There is no significant difference of genotype and alleles frequencies of EDN-lgene rs1800541、rs2070699、rs5370 between SCH group and control group (P>0.05).④There is no significant difference of genotype and alleles frequencies of ECE-1 gene rs3818416、rs5351 between SCH group and control group (P>0.05).
3. The results of FBAT in those member of CIFH pedigrees showed the following characteristics:①TDT analysis revealed that the frequency of transmission (from parent to the offspring with CH) of allele C of rs5335 polymorphism in CH increased significantly (P<0.05).②Haplotype analysis of EDNRA gene rs 1801708、rs5333、rs5335 revealed there were significant evidence for transmission disequilibrium with CH (P>0.05) in these haplotype:EDNRA rs1801708 rs5335 G-C, EDNRA rs5333 rs5335 T-C.③EDN1 gene rs1800541、rs2070699、rs5370 revealed no evidence for transmission disequilibrium with CH (P >0.05). Haplotyping and Haplotype Frequency Estimation of the 3 sites hasn't revealed significant results too(P>0.05).④Application of TDT to genotype data from EDNRB gene rs3818416、rs5351 polymorphisms and their Haplotype Frequency Estimation haven't got any positive results too.
4. Analysis of Endothelin family gene polymorphism and blood pressure level in Changsha Hans CH and control population:①In SCH group, the levels of diastolic pressure and mean arterial blood pressure of the GG gene type of rs5335 were significantly higher than those of the GC/CC gene type (p<0.05)。②In SCH group, the levels of systolic blood pressure of the AA gene type of ECE-1 gene rs5335 was significantly higher than that of the AG/GG gene type (p<0.05)。③There was no significant difference of levels of systolic blood pressure, diastolic pressure and mean arterial blood pressure between TT and GT/GG gene type of EDN1 gene rs1800541, between GG and GT/TT gene type of EDN1 gene rs2070699 and between GG and GT/TT gene type of EDN1 gene rs5370 (P>0.05)。④There was no significant difference of levels of systolic blood pressure, diastolic pressure and mean arterial blood pressure between AA and AG/GG gene type of EDNRB gene (P>0.05)。
Conclusions:
1. The EDNRA gene rs1801708、rs5333、rs5335 and EDNRB gene polymorphisms are associated with risks of CH in Changsha Han population.
2. The haplotypes of EDNRA rs1801708 rs5333 rs5335 G-T-C, EDNRA rs1801708 rs5335 G-C and rs5333 rs5335T-C may be related to with CH in Changsha Han population.
3. The polymorphism of EDNRA gene rs5335, ECE-1 gene rs212528 may have relation with the higher levels of blood pressure in the CH susceptible population in Changsha Han population, in which EDNRA gene rs5335 polymorphism may increase CH risk by influencing hypertension.
4. There may be no correlation between the polymorphism EDN-1 gene rs 1800541、rs2070699、rs5370,EDNRB gene rs3818416 and ECE-1 gene rs213045 and CH in Changsha Han population; The polymorphism of ECE-1 gene rs212528 may be related to the levels of blood pressure but not related to the susceptibility for CH.
方法：收集2006年1月至2009年12月在湘雅医院神经内科就诊的脑出血患者及部分家属的临床资料和外周血标本,所有病例均经CT和／或MRI确诊。研究对象均来自长沙地区汉族人群,包括：1.有家族聚集现象的脑出血家系组(cerebral hemorrhage with family history, CHFH):共65个家系,包括家系成员281例,男178例,女103例,分为以下亚组：①家系组脑出血患者组：65例,男46例,女19例,平均年龄(52.42±11.50)岁。②Ⅰ级亲属组(CHFH-I):133例(包括患者父母,子女及同胞兄弟姐妹),男69例,女64例,平均年龄(39.52±14.17)岁。③Ⅱ级亲属组(CHFH-II):36例,男26例,女10例,平均年龄(31.93±12.21)岁。④Ⅲ级亲属组(CHFH-II):10例,男7例,女3例,平均年龄(32.65±12.95)岁。⑤健康无血缘关系亲属(unaffected non-blood relatives)共37例,男30例,女7,平均年龄(47.68±7.64)岁。来自以上有家族聚集现象脑出血家系中与先证者无血缘关系的家庭成员,为先证者及其Ⅰ、Ⅱ、Ⅲ级亲属的配偶。2.散发性脑出血(Sporadic cerebral hemorrhage, SCH)组：195例,男133例,女62例,平均年龄(58.40±11.21)岁。3.正常对照(control)组：男75例,女41例,平均年龄(54.97±10.41)岁。
血压的测量：对所有受试对象的血压进行测量。根据2004年《中国高血压防治指南》公布的诊断标准,按收缩压≥140mmHg,和／或舒张压≥90mmHg诊断为高血压。
血脂的检测：采用氧化酶法测定甘油三脂(Triglyceride, TG)、总胆固醇(Total cholesterol,TC);测定高密度脂蛋白(High density lipoprotein, HDL)先用沉淀剂沉淀,再用氧化酶法测定上清液中的胆固醇；低密度脂蛋白(Low density lipoprotein, LDL)由Friedwald公式：LDL=(CHO-HDL)-TG/5计算。
基因分型：利用多重单碱基延伸SNP分型技术(Multiplex Snapshot)与DNA测序结合相互印证的方法检测所有研究对象内皮素-1合成调节途径4个基因10个SNPs位点多态性,包括：内皮素-1基因的rs1800541、rs2070699、rs5370,内皮素受体A基因rs1801708、rs5333、rs5335,内皮素受体B基因的rs3818416、rs5351,内皮素转化酶-1基因的rs2212528、rs213045。
统计：采用SPSS软件对散发性脑出血与正常对照组进行统计分析,两组间基因型与等位基因频率的差异用x2检验,不同基因型亚组间血压水平比较采用ANOVA方差分析。采用FBAT软件对有家族聚集现象脑出血家系的内皮素家族基因的多态性位点及其构建的单体型进行传递不平衡检验(Transmission disequilibrium test, TDT)。
结果：
1.基因多态性分布特征：长沙地区汉族人群存在EDN-1基因rs1800541、rs2070699、rs5370位点多态性,EDNRA基因rs1801708、rs5333、rs5335位点多态性,EDNRB基因rs3818416、rs5351位点多态性和ECE-1基因rs212528, rs213045多态性。这些多态位点基因型和等位基因分布频率均与世界其他地区人群的基因多态性分布存在不同程度种族差异性。
2.散发性脑出血与正常对照人群的病例-对照研究(case-control study)结果：①散发性脑出血组与对照组EDNRA基因rs1801708、rs5333各基因型及等位基因频率比较有统计学意义(p<0.05)；②散发性脑出血组与对照组EDNRB基因rs5351等位基因频率比较差异有统计学意义,散发组脑出血的最低等位基因G的频率(minor allele frequency, MAF)明显低于对照组(x 2=4.83,P<0.05)。③散发性脑出血组EDN-1基因rs1800541、rs2070699、rs5370多态各基因型及等位基因频率分布与对照组比较差异无统计学意义(P>0.05)。④散发性脑出血组与对照组ECE-1基因rs212528,rs213045多态各基因型及等位基因频率分布与对照组比较差异无统计学意义(P>0.05)。
3.有家族聚集现象脑出血家系的FBAT研究结果：①TDT分析发现EDNRA基因rs5335多态性位点的等位基因C向后代发生了过度传递现象(P<0.05)。EDNRA基因rs1801708、rs5333、rs5335多态位点构成的单体型G-T-C存在过度传递现象(P<0.05)；其中由EDNRA基因rs1801708和rs5335多态位点构成的单体型G-C、由EDNRA基因rs5333和rs5335多态位点构成的单体型T-C也存在过度传递现象(P<0.05)。③TDT分析未发现EDN-1基因rs1800541、rs2070699、rs5370多态性位点的等位基因存在传递不平衡现象(P>0.05),这三个位点构建单体型后进行TDT分析也未发现单个特异单体型存在过度传递现象(P>0.05)。④TDT分析未发现EDNRB基因rs3818416、rs5351多态位点从亲代到患病子代的过度传递现象(P>0.05),对他们构建的单体型分析也未发现过度传递现象(P>O.05)。⑤TDT分析未发现ECE-1基因rs212528,rs213045位点多态位点从亲代到患病子代的过度传递现象(P>0.05),对他们进行单体型构建后TDT分析未发现单个特异单体型存在过度传递现象(P>0.05)。
4.长沙汉族人群内皮素家族基因多态性对血压水平的影响：①散发性脑出血组EDNRA基因rs5335的GG基因型亚组与GC/CC基因型亚组间舒张压和平均动脉压之间存在显著性差异(P<0.05)。②散发性脑出血组ECE-1基因rs212528的AA与AG/GG基因型亚组之间的收缩压水平存在显著性差异(P<0.05)。③散发性脑出血组及对照组EDN-1基因rs1800541的TT基因型亚组与GT/GG基因型亚组之间、rs2070699位点GG基因型亚组与GT/TT基因型亚组之间、rs5370位点的GG基因型亚组与GT/TT基因型亚组之间的收缩压、舒张压和平均动脉压水平均无显著性差异(P>0.05)。④散发性脑出血组和对照组EDNRB基因rs5351各多态位点的基因型亚组之间的收缩压、舒张压和平均动脉压水平无显著性差异(P>0.05)。
结论：
1. EDNRA基因rs1801708、rs5333、rs5335, EDNRB基因rs5351位点多态位点可能与长沙汉族人群脑出血发病有关。
2. EDNRA基因rs1801708、rs5333、rs5335多态位点构成的单体型G-T-C、由EDNRA基因rs1801708和rs5335多态位点构成的单体型G-C、由EDNRA基因rs5333和rs5335多态位点构成的单体型T-C可能是长沙汉族人群脑出血的遗传易感因素之一。
3. EDNRA基因rs5335、ECE-1基因rs212528多态位点可能与长沙汉族脑出血易感人群的血压水平有关,其中EDNRA基因rs5335可能通过影响血压而增加了长沙汉族人群脑出血的发病风险。
4.EDN-1基因rs1800541、rs2070699、rs5370, EDNRB基因rs3818416, ECE-1基因rs213045位点多态性可能与长沙汉族人群脑出血和血压水平无关；ECE-1基因rs212528位点与与长沙汉族脑出血易感人群的血压水平有关但与脑出血的易感性无关。
Background and objective:
Cerebrovascular disease is the second commonest cause of death and leading cause of adult disability worldwide, of which cerebral hemorrhage (CH) represents a main subtype with high morbidity and disability. The etiology of CH is increasingly becoming an important concern in prevention and cure of cerebrovascular disease. Current studies on the clinical and molecular genetics stress this heterogeneous disease caused by the interactions among many minor genes and environmental factors. The study on candidate genes SNPs(single nucleotide polymorphisms) about CH will help us to understand the molecular nature of this disease and suggest a theory for prevention and treatment of CH.
Hypertension is an independent risk factor of CH and atherosclerosis is an important risk factor of CH, too. Our clinical epidemiology study on CH in the past dozen years has verified the conclusion that hypertension and atherosclerosis are risk factors related to CH, in which hypertension is the most important one. The human endothelin family gene is thought to play an important role in the development of atherosclerosis, hypertension and may increase the risk of CH. Up to now, there are few studies on the relationship between the polymorphism of Endothelin family gene and CH. Identification of gene polymorphisms of endothelins that confer susceptibility to CH and the development of genetic risk diagnosis systems may contribute to the personalized prevention of these conditions. Our aim is to investigate the correlations of the polymorphism of Endothelin family gene with CH in the Changsha Han ethnic group.
Methods:
All subjects came from Changsha Han population which were composed of 3 groups:(1) 281 members of 65 family with CH aggregation, including:①65 CH patients with family history:46 men and 19 women, averagely aged 52.42±11.50 years;②133 first-degree relatives:69 men and 64 women, averagely aged 39.52±14.17 years;③36 second-degree relatives:26 men and 10 women, averagely aged 31.93±12.21 years;④10 third-degree relatives:7 men and 3 women, averagely aged 32.65±12.95 years;⑤37 relatives with no kinship with proband:30 men and 7 women, averagely aged 47.68±7.64 years, who are spouses of the proband or the first-degree and second-degree relatives. (2)Sporadic cerebral hemorrhage (SCH) group:195 patients with sporadic cerebral hemorrhage,133 men and 62 women, averagely aged 58.40±11.21 years. (3) Control group:116 healthy controls,41 men and 75 women, averagely aged 54.97±10.41 years.
The measures of blood pressure:The blood pressure of every subject was measured and the hypertension was diagnosed according 2005 guidelines for The prevention and treatment of hypertension in China.
Serum lipid levels were tested:Total cholesterol (TC), High density lipoprotein (HDL) and triglycerides (TG) were measured by standard enzymatic methods. LDL cholesterol levels were calculated with the Friedewald formula (LDL=TC-HDL-TG/5).
Multiplex SNaPshot genotyping analysis and DNA sequencing were used to detect 10 SNPs in 4 genes associated with endogenous endothelins synthesis of some subjects, including:rs 1800541、rs2070699、rs5370 of endthelin-1 gene, rs1801708、rs5333、rs5335 of endothelin receptor A gene, rs3818416、rs5351 of endothelin receptor B gene and rs2212528、rs213045 of Endothelin-converting enzyme 1 gene.
The frequencies of the alleles and genotypes between the SCH group and control group were analyzed byχ2 analysis, and blood pressure levels were compared among genotypes by ANOVA using SPSS. The SNP and haplotype transmissions of the CH pedigrees were analyzed by transmission disequilibrium test (TDT) using FBAT computer program. Results:
1. The distribution of Endothelin family gene polymorphism in Changsha Hans population:There are EDN-1gene rs 1800541、rs2070699、rs5370 polymorphisms, EDNRA gene rs 1801708、rs5333、rs5335 polymorphisms, EDNRB gene rs3818416、rs5351 polymorphisms and ECE-1 gene rs3818416、rs5351 polymorphisms in Changsha Han population. These gene polymorphisms in Changsha Han population revealed obvious racial difference comparing with those of other regions in the world in different extents.
2. The results of the case-control study in SCH and normal controls were as follows:①There is significant difference of genotype and allele frequencies of EDNRA gene rs180178、rs5333 between SCH group and control group(p<0.05).②The frequencies of G allele (MAF) of EDNRB gene rs5351 was significantly lower in SCH group than those in control group (p< 0.05).③There is no significant difference of genotype and alleles frequencies of EDN-lgene rs1800541、rs2070699、rs5370 between SCH group and control group (P>0.05).④There is no significant difference of genotype and alleles frequencies of ECE-1 gene rs3818416、rs5351 between SCH group and control group (P>0.05).
3. The results of FBAT in those member of CIFH pedigrees showed the following characteristics:①TDT analysis revealed that the frequency of transmission (from parent to the offspring with CH) of allele C of rs5335 polymorphism in CH increased significantly (P<0.05).②Haplotype analysis of EDNRA gene rs 1801708、rs5333、rs5335 revealed there were significant evidence for transmission disequilibrium with CH (P>0.05) in these haplotype:EDNRA rs1801708 rs5335 G-C, EDNRA rs5333 rs5335 T-C.③EDN1 gene rs1800541、rs2070699、rs5370 revealed no evidence for transmission disequilibrium with CH (P >0.05). Haplotyping and Haplotype Frequency Estimation of the 3 sites hasn't revealed significant results too(P>0.05).④Application of TDT to genotype data from EDNRB gene rs3818416、rs5351 polymorphisms and their Haplotype Frequency Estimation haven't got any positive results too.
4. Analysis of Endothelin family gene polymorphism and blood pressure level in Changsha Hans CH and control population:①In SCH group, the levels of diastolic pressure and mean arterial blood pressure of the GG gene type of rs5335 were significantly higher than those of the GC/CC gene type (p<0.05)。②In SCH group, the levels of systolic blood pressure of the AA gene type of ECE-1 gene rs5335 was significantly higher than that of the AG/GG gene type (p<0.05)。③There was no significant difference of levels of systolic blood pressure, diastolic pressure and mean arterial blood pressure between TT and GT/GG gene type of EDN1 gene rs1800541, between GG and GT/TT gene type of EDN1 gene rs2070699 and between GG and GT/TT gene type of EDN1 gene rs5370 (P>0.05)。④There was no significant difference of levels of systolic blood pressure, diastolic pressure and mean arterial blood pressure between AA and AG/GG gene type of EDNRB gene (P>0.05)。
Conclusions:
1. The EDNRA gene rs1801708、rs5333、rs5335 and EDNRB gene polymorphisms are associated with risks of CH in Changsha Han population.
2. The haplotypes of EDNRA rs1801708 rs5333 rs5335 G-T-C, EDNRA rs1801708 rs5335 G-C and rs5333 rs5335T-C may be related to with CH in Changsha Han population.
3. The polymorphism of EDNRA gene rs5335, ECE-1 gene rs212528 may have relation with the higher levels of blood pressure in the CH susceptible population in Changsha Han population, in which EDNRA gene rs5335 polymorphism may increase CH risk by influencing hypertension.
4. There may be no correlation between the polymorphism EDN-1 gene rs 1800541、rs2070699、rs5370,EDNRB gene rs3818416 and ECE-1 gene rs213045 and CH in Changsha Han population; The polymorphism of ECE-1 gene rs212528 may be related to the levels of blood pressure but not related to the susceptibility for CH.
引文
[1]Liu, M.,Wu, B.,Wang, W. Z., et al. Stroke in China:epidemiology, prevention, and management strategies[J]. Lancet Neurol,2007,6(5):456-64.
[2]Woo, D.,Sauerbeck, L. R.,Kissela, B. M., et al. Genetic and environmental risk factors for intracerebral hemorrhage:preliminary results of a population-based study[J]. Stroke,2002,33(5):1190-5.
[3]Sessa, M. Intracerebral hemorrhage and hypertension[J]. Neurol Sci,2008,29 Suppl 2:S258-9.
[4]Hanggi, D.,Steiger, H. J. Spontaneous intracerebral haemorrhage in adults:a literature overview[J]. Acta Neurochir (Wien),2008,150(4):371-9; discussion 379.
[5]Elijovich, L.,Patel, P. V.,Hemphill, J. C.,3rd. Intracerebral hemorrhage[J]. Semin Neurol,2008,28(5):657-67.
[6]Sturgeon, J. D.,Folsom, A. R.,Longstreth, W. T., Jr., et al. Risk factors for intracerebral hemorrhage in a pooled prospective study[J]. Stroke,2007,38(10): 2718-25.
[7]Ariesen, M. J.,Claus, S. P.,Rinkel, G. J., et al. Risk factors for intracerebral hemorrhage in the general population:a systematic review[J]. Stroke,2003, 34(8):2060-5.
[8]Yang, Q. D.,Niu, Q.,Zhou, Y. H., et al. Incidence of cerebral hemorrhage in the Changsha community. A prospective study from 1986 to 2000[J]. Cerebrovasc Dis,2004,17(4):303-13.
[9]Fisher, C. M. Pathological observations in hypertensive cerebral hemorrhage [J]. J Neuropathol Exp Neurol,1971,30(3):536-50.
[10]Manno, E. M.,Atkinson, J. L.,Fulgham, J. R., et al. Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage[J]. Mayo Clin Proc,2005,80(3):420-33.
[11]Tamaki, T.,Oyama, K.,Uematsu, M., et al. [An ultrasonic study of the relationship between extracranial carotid atherosclerosis and intracerebral hemorrhage][J]. No Shinkei Geka,2000,28(2):147-52.
[12]Mazighi, M.,Labreuche, J.,Gongora-Rivera, F., et al. Autopsy prevalence of proximal extracranial atherosclerosis in patients with fatal stroke [J]. Stroke,2009,40(3):713-8.
[13]Inagawa, T. Risk factors for primary intracerebral hemorrhage in patients in Izumo City, Japan[J]. Neurosurg Rev,2007,30(3):225-34; discussion 234.
[14]Zhou, J. F.,Wang, J. Y.,Luo, Y. E., et al. Influence of hypertension, lipometabolism disorders, obesity and other lifestyles on spontaneous intracerebral hemorrhage [J]. Biomed Environ Sci,2003,16(3):295-303.
[15]刘宝琼.长沙汉族人群VLDL/LDL代谢途径相关基因多态性与脑出血的关系研究：[博士学位论文].长沙：中南大学,2009
[16]Dickinson, C. J. Why are strokes related to hypertension? Classic studies and hypotheses revisited[J].J Hypertens,2001,19(9):1515-21.
[17]Yanagisawa, M.,Kurihara, H.,Kimura, S., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells[J]. Nature,1988,332(6163): 411-5.
[18]Inoue, A.,Yanagisawa, M.,Kimura, S., et al. The human endothelin family:three structurally and pharmacologically distinct isopeptides predicted by three separate genes[J]. Proc Natl Acad Sci U S A,1989,86(8):2863-7.
[19]von Websky, K.,Heiden, S.,Pfab, T., et al. Pathophysiology of the endothelin system-lessons from genetically manipulated animal models[J]. Eur J Med Res,2009,14(1):1-6.
[20]Rubanyi, G. M.,Polokoff, M. A. Endothelins:molecular biology, biochemistry, pharmacology, physiology, and pathophysiology [J]. Pharmacol Rev,1994,46(3): 325-415.
[21]Garncarczyk, A.,Jurzak, M.,Gojniczek, K. [Characteristic of the endogenous peptides-endothelins and their role in the connective tissue fibrosis][J]. Wiad Lek,2008,61(4-6):126-34.
[22]Sorrentino, S.,Forleo, C.,Iacoviello, M., et al. Endothelin system polymorphisms in tilt test-induced vasovagal syncope[J]. Clin Auton Res,2009.
[23]Schiffrin, E. L. Role of endothelin-1 in hypertension and vascular disease[J]. Am J Hypertens,2001,14(6 Pt 2):83S-89S.
[24]Shichiri, M.,Hirata, Y.,Ando, K., et al. Plasma endothelin levels in hypertension and chronic renal failure[J]. Hypertension,1990,15(5):493-6.
[25]Shreenivas, S.,Oparil, S. The role of endothelin-1 in human hypertension[J]. Clin Hemorheol Microcirc,2007,37(1-2):157-78.
[26]Taddei, S.,Virdis, A.,Ghiadoni, L., et al. Role of endothelin in the control of peripheral vascular tone in human hypertension[J]. Heart Fail Rev,2001,6(4): 277-85.
[27]Schneider, M. P.,Boesen, E. I.,Pollock, D. M. Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease[J]. Annu Rev Pharmacol Toxicol,2007,47:731-59.
[28]Roquer, J.,Segura, T.,Serena, J., et al. Endothelial dysfunction, vascular disease and stroke:the ARTICO study[J]. Cerebrovasc Dis,2009,27 Suppl 1:25-37.
[29]Edvinsson, L. Cerebrovascular endothelin receptor upregulation in cerebral ischemia[J]. Curr Vasc Pharmacol,2009,7(1):26-33.
[30]Giannopoulos, S.,Kosmidou, M.,Hatzitolios, A. I., et al. Measurements of endothelin-1, C-reactive protein and fibrinogen plasma levels in patients with acute ischemic stroke[J]. Neurol Res,2008,30(7):727-30.
[31]Moldes, O.,Sobrino, T.,Millan, M., et al. High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA[J]. Stroke,2008,39(7):2006-10.
[32]Ivey, M. E.,Osman, N.,Little, P. J. Endothelin-1 signalling in vascular smooth muscle:pathways controlling cellular functions associated with atherosclerosis [J]. Atherosclerosis,2008,199(2):237-47.
[33]张微微,黄勇华.脑出血患者脑反应性星形细胞内皮素-1的表达[J].中国神经精神疾病杂志,2001,27(1)：41-42.
[34]赵永波,王忠卿.血浆内皮素水平变化及其临床意义[J].临床神经病学杂志,2002,15(6)：361-362.
[35]李永强,郑玉明,刘立华.脑出血患者内皮素与血肿周围脑水肿形成关系的研究[J].临床医药实践,2006,15(9)：674-675.
[36]武婕,章柏松.ET和NO在脑出血中的变化以及硫酸镁的干预作用[J].中国血液流变学杂志,2004,14(1)：32-36.
[37]MacClellan, L. R.,Howard, T. D.,Cole, J. W., et al. Relation of candidate genes that encode for endothelial function to migraine and stroke:the Stroke Prevention in Young Women study[J]. Stroke,2009,40(10):e550-7.
[38]Lacolley, P.,Challande, P.,Osborne-Pellegrin, M., et al. Genetics and pathophysiology of arterial stiffness[J]. Cardiovasc Res,2009,81(4):637-48.
[39]Rahman, T.,Baker, M.,Hall, D. H., et al. Common genetic variation in the type A endothelin-1 receptor is associated with ambulatory blood pressure:a family study[J]. J Hum Hypertens,2008,22(4):282-8.
[40]Popov, A. F.,Schulz, E. G.,Hinz, J., et al. Impact of endothelin-1 Lys198Asn polymorphism on coronary artery disease and endorgan damage in hypertensives[J]. Coron Artery Dis,2008,19(7):429-34.
[41]Panoulas, V. F.,Douglas, K. M.,Smith, J. P., et al. Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis[J]. Endothelium,2008,15(4):203-12.
[42]Lee, J.,Cheong, S. S.,Kim, J. Association of endothelin-1 gene polymorphisms with variant angina in Korean patients[J]. Clin Chem Lab Med,2008,46(11): 1575-80.
[43]Schiffrin, E. L.,Deng, L. Y.,Sventek, P., et al. Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension[J]. J Hypertens,1997,15(1):57-63.
[44]Tiret, L.,Poirier, O.,Hallet, V., et al. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people[J]. Hypertension,1999,33(5):1169-74.
[45]Asai, T.,Ohkubo, T.,Katsuya, T., et al. Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects:the Ohasama Study [J]. Hypertension,2001,38(6):1321-4.
[46]Barath, A.,Endreffy, E.,Bereczki, C., et al. Endothelin-1 gene and endothelial nitric oxide synthase gene polymorphisms in adolescents with juvenile and obesity-associated hypertension[J]. Acta Physiol Hung,2007,94(1-2):49-66.
[47]汤旭磊.内皮素受体研究进展[J].兰州医学院学报,2000,26(1)：58-61.
[48]Treiber, F. A.,Barbeau, P.,Harshfield, G., et al. Endothelin-1 gene Lys198Asn polymorphism and blood pressure reactivity [J]. Hypertension,2003,42(4): 494-9.
[49]Banno, M.,Hanada, H.,Kamide, K., et al. Association of genetic polymorphisms of endothelin-converting enzyme-1 gene with hypertension in a Japanese population and rare missense mutation in preproendothelin-1 in Japanese hypertensives[J]. Hypertens Res,2007,30(6):513-20.
[50]Nicaud, V.,Poirier, O.,Behague, I., et al. Polymorphisms of the endothelin-A and-B receptor genes in relation to blood pressure and myocardial infarction:the Etude Cas-Temoins sur l'Infarctus du Myocarde (ECTIM) Study [J]. Am J Hypertens,1999,12(3):304-10.
[51]Funalot, B.,Courbon, D.,Brousseau, T., et al. Genes encoding endothelin-converting enzyme-1 and endothelin-1 interact to influence blood pressure in women:the EVA study[J]. J Hypertens,2004,22(4):739-43.
[52]Tanaka, C.,Kamide, K.,Takiuchi, S., et al. Evaluation of the Lys198Asn and-134delA genetic polymorphisms of the endothelin-1 gene[J]. Hypertens Res,2004,27(5):367-71.
[53]Caprioli, J.,Mele, C.,Mossali, C., et al. Polymorphisms of EDNRB, ATG, and ACE genes in salt-sensitive hypertension[J]. Can J Physiol Pharmacol,2008, 86(8):505-10.
[54]Lajemi, M.,Gautier, S.,Poirier, O., et al. Endothelin gene variants and aortic and cardiac structure in never-treated hypertensives [J]. Am J Hypertens,2001,14(8 Pt 1):755-60.
[55]Yasuda, H.,Kamide, K.,Takiuchi, S., et al. Association of single nucleotide polymorphisms in endothelin family genes with the progression of atherosclerosis in patients with essential hypertension[J]. J Hum Hypertens,2007,21(11):883-92.
[56]Jin, Z.,Luxiang, C.,Huadong, Z., et al. C-338A polymorphism of the endothelin-converting enzyme-1 gene and the susceptibility to carotid atherosclerosis[J]. Microvasc Res,2009.
[57]Kozak, M.,Holla, L. I.,Krivan, L., et al. Endothelin-1 gene polymorphism in the identification of patients at risk for malignant ventricular arrhythmia[J]. Med Sci Monit,2002,8(5):BR164-7.
[58]Buhler, K.,Ufer, M.,Muller-Marbach, A., et al. Risk of coronary artery disease as influenced by variants of the human endothelin and endothelin-converting enzyme genes[J]. Pharmacogenet Genomics,2007,17(1):77-83.
[59]Wang, L. S.,Tang, N. P.,Zhu, H. J., et al. Endothelin-converting enzyme-lb C-338A polymorphism is associated with the increased risk of coronary artery disease in Chinese population[J]. Clin Chim Acta,2007,384(1-2):75-9.
[60]Gormley, K.,Bevan, S.,Hassan, A., et al. Polymorphisms in genes of the endothelin system and cerebral small-vessel disease[J]. Stroke,2005,36(8): 1656-60.
[61]张乐,杨期东,曾艺,等.载脂蛋白B基因C7673T多态与有家族聚集现象脑出血的关[J].中华医学遗传学杂志,2008,25(2)：145-149.
[62]刘宝琼,张乐,杨期东,等.载脂蛋白B基因3’-VNTR多态性与家族聚集性脑出血的关系[J].中国神经精神疾病杂志,2009,35(5)：269-273.
[63]胡中扬,张乐,杨期东,等.APOB基因G11039A多态性与家族聚集性脑出血的相关性研究[J].卒中与神经疾病,2008,15(05)：268-272.
[64]Fischer, C.,Beckmann, L.,Majoram, P., et al. Haplotype sharing analysis with SNPs in candidate genes:the Genetic Analysis Workshop 12 example[J]. Genet Epidemiol,2003,24(1):68-73.
[65]Schork, N. J.,Fallin, D.,Lanchbury, J. S. Single nucleotide polymorphisms and the future of genetic epidemiology [J]. Clin Genet,2000,58(4):250-64.
[66]Hirschhorn, J. N.,Lohmueller, K.,Byrne, E., et al. A comprehensive review of genetic association studies[J]. Genet Med,2002,4(2):45-61.
[67]Salisbury, B. A.,Pungliya, M.,Choi, J. Y., et al. SNP and haplotype variation in the human genome[J]. Mutat Res,2003,526(1-2):53-61.
[68]Li, J.,Pan, Y. C.,Li, Y. X., et al. [Analysis and application of SNP and haplotype in the human genome][J]. Yi Chuan Xue Bao,2005,32(8):879-89.
[69]Palmer, L. J.,Cardon, L. R. Shaking the tree:mapping complex disease genes with linkage disequilibrium[J]. Lancet,2005,366(9492):1223-34.
[70]马明明,张乐,杨期东.脑卒中的遗传学研究策略及研究进展[J].中华神经科杂志,2009,42(12)：849-851.
[71]Laird, N. M.,Lange, C. Family-based designs in the age of large-scale gene-association studies[J]. Nat Rev Genet,2006,7(5):385-94.
[72]Sacco, R.,Papaleo, V.,Hager, J., et al. Case-control and family-based association studies of candidate genes in autistic disorder and its endophenotypes:TPH2 and GLO1[J]. BMC Med Genet,2007,8:11.
[73]Davenport, A. P.,Maguire, J. J. Endothelin[J]. Handb Exp Pharmacol,2006, (176 Pt 1):295-329.
[74]d'Uscio, L. V.,Barton, M.,Shaw, S., et al. Endothelin in atherosclerosis: importance of risk factors and therapeutic implications [J]. J Cardiovasc Pharmacol,2000,35(4 Suppl 2):S55-59.
[75]Brunner, F.,Bras-Silva, C.,Cerdeira, A. S., et al. Cardiovascular endothelins: essential regulators of cardiovascular homeostasis[J]. Pharmacol Ther,2006, 111(2):508-31.
[76]Shah, R. Endothelins in health and disease[J]. Eur J Intern Med,2007,18(4): 272-82.
[77]Bousette, N.,Giaid, A. Endothelin-1 in atherosclerosis and other vasculopathies[J]. Can J Physiol Pharmacol,2003,81(6):578-87.
[78]阎瑛,黄锦华.血浆内皮素(ET)对脑出血、癫痫诊断价值的探讨[J].2005,16(1)：149-150.
[79]Lee, M. E.,Bloch, K. D.,Clifford, J. A., et al. Functional analysis of the endothelin-1 gene promoter. Evidence for an endothelial cell-specific cis-acting sequence[J]. J Biol Chem,1990,265(18):10446-50.
[80]Jin, J. J.,Nakura, J.,Wu, Z., et al. Association of endothelin-1 gene variant with hypertension[J]. Hypertension,2003,41(1):163-7.
[81]Nauck, M.,Warnick, G. R.,Rifai, N. Methods for measurement of LDL-cholesterol:a critical assessment of direct measurement by homogeneous assays versus calculation [J]. Clin Chem,2002,48(2):236-54.
[82]Rost, N. S.,Greenberg, S. M.,Rosand, J. The genetic architecture of intracerebral Hemorrhage[J]. Stroke,2008,39(7):2166-2173.
[83]McPherson, R.,Pertsemlidis, A.,Kavaslar, N., et al. A common allele on chromosome 9 associated with coronary heart disease[J]. Science,2007, 316(5830):1488-91.
[84]Haines, J. L.,Pericak-Vance, M. A. Rapid dissection of the genetic risk of age-related macular degeneration:achieving the promise of the genomic era[J]. JAMA,2007,297(4):401-2.
[85]Saxena, R.,Voight, B. F.,Lyssenko, V., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels [J]. Science,2007, 316(5829):1331-6.
[86]Hampe, J.,Franke, A.,Rosenstiel, P., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1[J]. Nat Genet,2007,39(2):207-11.
[87]Hafler, D. A.,Compston, A.,Sawcer, S., et al. Risk alleles for multiple sclerosis identified by a genomewide study[J]. N Engl J Med,2007,357(9):851-62.
[88]Matarin, M.,Brown, W. M.,Scholz, S., et al. A genome-wide genotyping study in patients with ischaemic stroke:initial analysis and data release[J]. Lancet Neurol,2007,6(5):414-20.
[89]张学军.复杂疾病的遗传学研究策略[J].安徽医科大学学报,2007,42(3)：237-240.
[90]Alberts, M. J.,McCarron, M. O.,Hoffmann, K. L., et al. Familial clustering of intracerebral hemorrhage:a prospective study in North Carolina[J]. Neuroepidemiology,2002,21(1):18-21.
[91]Kiely, D. K.,Wolf, P. A.,Cupples, L. A., et al. Familial aggregation of stroke. The Framingham Study[J]. Stroke,1993,24(9):1366-71.
[92]Feigin, V. L. Stroke epidemiology in the developing world[J]. Lancet,2005, 365(9478):2160-1.
[93]胡中扬,张乐,杨期东等.ApoB基因多态性与长沙汉族人群脑出血的关系及其对血脂水平的影响[J].中南大学学报：医学版,2008,33(6)：494-499.
[94]Woo, D.,Sekar, P.,Chakraborty, R., et al. Genetic epidemiology of intracerebral hemorrhage[J]. J Stroke Cerebrovasc Dis,2005,14(6):239-43.
[95]Rosand, J.,Altshuler, D. Human genome sequence variation and the search for genes influencing stroke[J]. Stroke,2003,34(10):2512-6.
[96]Wityk, R. J.,Caplan, L. R. Hypertensive intracerebral hemorrhage. Epidemiology and clinical pathology[J]. Neurosurg Clin N Am,1992,3(3): 521-32.
[97]He, J.,Klag, M. J.,Wu, Z., et al. Stroke in the People's Republic of China. I. Geographic variations in incidence and risk factors[J]. Stroke,1995,26(12): 2222-7.
[98]黄勇华,张微微,郝小淑.内皮素与中枢神经系统疾病[J].北京医学,2000,22(1)：43-45.
[99]李丽华,赵炳让.内皮素-1基因多态性及其与高血压的关系[J].医学综述,2008,14(17)：2595-2597.
[100]Schweizer, A.,Valdenaire, O.,Nelbock, P., et al. Human endothelin-converting enzyme (ECE-1):three isoforms with distinct subcellular localizations [J]. Biochem J,1997,328 (Pt 3):871-7.
[101]吴孟津,廖端芳,彭翠英,等.湖南娄底地区汉族人群内皮素基因rs5370G/T多态性研究[J].实用预防医学,2007,14(3)：620-622.
[102]Zhu, G.,Carlsen, K.,Carlsen, K. H., et al. Polymorphisms in the endothelin-1 (EDN1) are associated with asthma in two populations [J]. Genes Immun,2008, 9(1):23-9.
[103]Miyata, S.,Ohhata, N.,Murai, H., et al. WS009 A and B, new endothelin receptor antagonists isolated from Streptomyces sp. no.89009. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities [J]. J Antibiot (Tokyo),1992,45(7):1029-40.
[104]Imokawa, G.,Yada, Y.,Kimura, M. Signalling mechanisms of endothelin-induced mitogenesis and melanogenesis in human melanocytes[J]. Biochem J,1996,314 (Pt1):305-12.
[105]Highsmith, R. F.,Pang, D. C.,Rapoport, R. M. Endothelial cell-derived vasoconstrictors:mechanisms of action in vascular smooth muscle[J]. J Cardiovasc Pharmacol,1989,13 Suppl 5:S36-44; discussion S45.
[106]Miyauchi, T.,Ishikawa, T.,Tomobe, Y., et al. Characteristics of pressor response to endothelin in spontaneously hypertensive and Wistar-Kyoto rats[J]. Hypertension,1989,14(4):427-34.
[107]Inagami, T.,Naruse, M.,Hoover, R. Endothelium as an endocrine organ[J]. Annu Rev Physiol,1995,57:171-89.
[108]Halcox, J. P.,Nour, K. R.,Zalos, G, et al. Endogenous endothelin in human coronary vascular function:differential contribution of endothelin receptor types A and B[J]. Hypertension,2007,49(5):1134-41.
[109]Crowley, R. W.,Medel, R.,Kassell, N. F., et al. New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage [J]. Drug Discov Today,2008,13(5-6):254-60.
[110]Iemitsu, M.,Maeda, S.,Otsuki, T., et al. Polymorphism in endothelin-related genes limits exercise-induced decreases in arterial stiffness in older subjects[J]. Hypertension,2006,47(5):928-36.
[111]Levin, E. R. Endothelins[J]. N Engl J Med,1995,333(6):356-63.
[112]Kedzierski, R. M.,Yanagisawa, M. Endothelin system:the double-edged sword in health and disease[J]. Annu Rev Pharmacol Toxicol,2001,41:851-76.
[113]Van Renterghem, C.,Vigne, P.,Barhanin, J., et al. Molecular mechanism of action of the vasoconstrictor peptide endothelin[J]. Biochem Biophys Res Commun,1988,157(3):977-85.
[114]Hirata, Y.,Yoshimi, H.,Takata, S., et al. Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells[J]. Biochem Biophys Res Commun,1988,154(3):868-75.
[115]Mohacsi, A.,Magyar, J.,Tamas, B., et al. Effects of endothelins on cardiac and vascular cells:new therapeutic target for the future?[J]. Curr Vasc Pharmacol,2004,2(1):53-63.
[116]Dhaun, N.,Goddard, J.,Kohan, D. E., et al. Role of endothelin-1 in clinical hypertension:20 years on[J]. Hypertension,2008,52(3):452-9.
[117]Benjafield, A. V.,Katyk, K.,Morris, B. J. Association of EDNRA, but not WNK4 or FKBP1B, polymorphisms with essential hypertension[J]. Clin Genet,2003, 64(5):433-8.
[118]Colombo, M. G.,Ciofini, E.,Paradossi, U., et al. ET-1 Lys198Asn and ET(A) receptor H323H polymorphisms in heart failure. A case-control study[J]. Cardiology,2006,105(4):246-52.
[119]Tzourio, C.,E1 Amrani, M.,Poirier, O., et al. Association between migraine and endothelin type A receptor (ETA-231 A/G) gene polymorphism [J]. Neurology,2001,56(10):1273-7.
[120]李丽华,赵炳让.内皮素-1基因Lysl98Asn及TaqI多态性与原发性高血压关系的研究[J].中国分子心脏病学杂志,2008,8(3)：165-169.
[121]吕晔,于东.血浆内皮素1与高血压脑出血的关系[J].中国综合临床,2004,20(9)：781-782.
[122]Pinet, F. [What is the role of endothelin system?][J]. Med Sci (Paris),2004, 20(3):339-45.
[123]Doggrell, S. A. The endothelin system and its role in acute myocardial infarction[J]. Expert Opin Ther Targets,2004,8(3):191-201.
[124]Reid, K.,Turnley, A. M.,Maxwell, G. D., et al. Multiple roles for endothelin in melanocyte development:regulation of progenitor number and stimulation of differentiation[J]. Development,1996,122(12):3911-9.
[125]Hynynen, M. M.,Khalil, R. A. The vascular endothelin system in hypertension-recent patents and discoveries [J]. Recent Pat Cardiovasc Drug Discov,2006,1(1):95-108.
[126]Jasmin, J. F.,Dupuis, J. Evaluation of luminal endothelin-converting enzyme activity in the pulmonary and coronary circulations [J]. J Cardiovasc Pharmacol,2004,43(1):21-5.
[127]Turner, A. J.,Murphy, L. J. Molecular pharmacology of endothelin converting enzymes[J]. Biochem Pharmacol,1996,51(2):91-102.
[128]杨波,江本宪昭,中山和彦.ECE-1基因敲除小鼠RAAS系统激活及其意义[J].心血管康复医学杂志,2007,16(6)：534-536.
[129]Ihling, C.,Bohrmann, B.,Schaefer, H. E., et al. Endothelin-1 and endothelin converting enzyme-1 in human atherosclerosis-novel targets for pharmacotherapy in atherosclerosis[J]. Curr Vasc Pharmacol,2004,2(3):249-58.
[130]Scacchi, R.,Gambina, G.,Broggio, E., et al. C-338A polymorphism of the endothelin-converting enzyme (ECE-1) gene and the susceptibility to sporadic late-onset Alzheimer's disease and coronary artery disease[J]. Disease Markers,2008,24(3):175-179.
[1]Penna C, Rastaldo R, Mancardi D, et al. Effect of endothelins on the cardiovascular system[J]. J Cardiovasc Med (Hagerstown).2006,7(9):645-652.
[2]Iglarz M, Clozel M. Mechanisms of ET-1-induced endothelial dysfunction[J]. J Cardiovasc Pharmacol.2007,50(6):621-628.
[3]Caprioli J, Mele C, Mossali C, et al. Polymorphisms of EDNRB, ATG, and ACE genes in salt-sensitive hypertension[J]. Can J Physiol Pharmacol.2008, 86(8):505-510.
[4]Arjomand-Nahad F, Landt O, Stangl K, et al. Fifteen polymorphisms in endothelin-1, endothelin-2 and endothelin-receptor-A genotyped by four duplex assays and seven simple assays on a LightCycler using hybridization probes[J]. Clin Chem Lab Med.2006,44(8):929-932.
[5]Yasuda H, Kamide K, Takiuchi S, et al. Association of single nucleotide polymorphisms in endothelin family genes with the progression of atherosclerosis in patients with essential hypertension[J]. J Hum Hypertens.2007, 21(11):883-892.
[6]Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells[J]. Nature.1988,332(6163): 411-415.
[7]Bohm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease[J]. Cardiovasc Res.2007,76(1):8-18.
[8]Mohacsi A, Magyar J, Tamas B, et al. Effects of endothelins on cardiac and vascular cells:new therapeutic target for the future?[J]. Curr Vasc Pharmacol. 2004,2(1):53-63.
[9]Gross PM, Zochodne DW, Wainman DS, et al. Intraventricular endothelin-1 uncouples the blood flow:metabolism relationship in periventricular structures of the rat brain:involvement of L-type calcium channels[J]. Neuropeptides.1992, 22(3):155-165.
[10]Zochodne DW, Ho LT, Gross PM. Acute endoneurial ischemia induced by epineurial endothelin in the rat sciatic nerve[J]. Am J Physiol.1992,263(6 Pt 2): H1806-1810.
[11]Andresen J, Shafi NI, Bryan RM, Jr. Endothelial influences on cerebrovascular tone[J]. J Appl Physiol.2006,100(1):318-327.
[12]Shreenivas S, Oparil S. The role of endothelin-1 in human hypertension[J]. Clin Hemorheol Microcirc.2007,37(1-2):157-178.
[13]Miyauchi T, Masaki T. Pathophysiology of endothelin in the cardiovascular system[J]. Annu Rev Physiol.1999,61:391-415.
[14]Ivey ME, Osman N, Little PJ. Endothelin-1 signalling in vascular smooth muscle:pathways controlling cellular functions associated with atherosclerosis [J]. Atherosclerosis.2008,199(2):237-247.
[15]Crowley RW, Medel R, Kassell NF, et al. New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage[J]. Drug Discov Today.2008,13(5-6):254-260.
[16]Giannopoulos S, Kosmidou M, Hatzitolios AI, et al. Measurements of endothelin-1, C-reactive protein and fibrinogen plasma levels in patients with acute ischemic stroke[J]. Neurol Res.2008,30(7):727-730.
[17]Moldes O, Sobrino T, Millan M, et al. High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA[J]. Stroke.2008,39(7):2006-2010.
[18]Fouyas IP, Brennan P, Kelly PA, et al. The role of endothelin in the cerebrovascular response following intracerebral haemorrhage:experimental studies using the endothelin antagonist SB209670[J]. Br J Neurosurg.2008, 22(1):35-39.
[19]张颖,冯加纯.内皮素作用机制及其与脑出血的相关性研究进展[J].神经疾病与精神卫生.2003,3(6)：488-490.
[20]Tiret L, Poirier O, Hallet V, et al. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people[J]. Hypertension.1999,33(5):1169-1174.
[21]Jin JJ, Nakura J, Wu Z, et al. Association of endothelin-1 gene variant with hypertension[J]. Hypertension.2003,41(1):163-167.
[22]Barden AE, Herbison CE, Beilin LJ, et al. Association between the endothelin-1 gene Lys198Asn polymorphism blood pressure and plasma endothelin-1 levels in normal and pre-eclamptic pregnancy [J]. J Hypertens.2001, 19(10):1775-1782.
[23]Banno M, Hanada H, Kamide K, et al. Association of genetic polymorphisms of endothelin-converting enzyme-1 gene with hypertension in a Japanese population and rare missense mutation in preproendothelin-1 in Japanese hypertensives[J]. Hypertens Res.2007,30(6):513-520.
[24]Treiber FA, Barbeau P, Harshfield G, et al. Endothelin-1 gene Lys198Asn polymorphism and blood pressure reactivity [J]. Hypertension.2003,42(4): 494-499.
[25]Funalot B, Courbon D, Brousseau T, et al. Genes encoding endothelin-converting enzyme-1 and endothelin-1 interact to influence blood pressure in women:the EVA study[J]. J Hypertens.2004,22(4):739-743.
[26]Barath A, Endreffy E, Bereczki C, et al. Endothelin-1 gene and endothelial nitric oxide synthase gene polymorphisms in adolescents with juvenile and obesity-associated hypertension[J]. Acta Physiol Hung.2007,94(1-2):49-66.
[27]Panoulas VF, Douglas KM, Smith JP, et al. Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis[J]. Endothelium.2008,15(4):203-212.
[28]Wiltshire S, Powell BL, Jennens M, et al. Investigating the association between K198N coding polymorphism in EDN1 and hypertension, lipoprotein levels, the metabolic syndrome and cardiovascular disease[J]. Hum Genet.2008, 123(3):307-313.
[29]Rahman T, Baker M, Hall DH, et al. Common genetic variation in the type A endothelin-1 receptor is associated with ambulatory blood pressure:a family study[J]. J Hum Hypertens.2008,22(4):282-288.
[30]Kozak M, Holla LI, Krivan L, et al. Endothelin-1 gene polymorphism in the identification of patients at risk for malignant ventricular arrhythmia[J]. Med Sci Monit.2002,8(5):BR164-167.
[31]Buhler K, Ufer M, Muller-Marbach A et al. Risk of coronary artery disease as influenced by variants of the human endothelin and endothelin-converting enzyme genes[J]. Pharmacogenet Genomics.2007,17(1):77-83.
[32]Popov AF, Schulz EG, Hinz J, et al. Impact of endothelin-1 Lys198Asn polymorphism on coronary artery disease and endorgan damage in hypertensives [J]. Coron Artery Dis.2008,19(7):429-434.
[33]Pare G, Serre D, Brisson D, et al. Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol[J]. Am J Hum Genet.2007,80(4):673-682.
[34]Wang LS, Tang NP, Zhu HJ, et al. Endothelin-converting enzyme-lb C-338A polymorphism is associated with the increased risk of coronary artery disease in Chinese population[J]. Clin Chim Acta.2007,384(1-2):75-79.
[35]Jin Z, Luxiang C, Huadong Z, et al. C-338A polymorphism of the endothelin-converting enzyme-1 gene and the susceptibility to carotid atherosclerosis[J]. Microvasc Res.2009.
[36]Bleumink GS, Schut AF, Sturkenboom MC et al. Genetic polymorphisms and heart failure[J]. Genet Med.2004,6(6):465-474.
[37]Colombo MG, Ciofini E, Paradossi U, et al. ET-1 Lys198Asn and ET(A) receptor H323H polymorphisms in heart failure. A case-control study[J]. Cardiology.2006,105(4):246-252.
[38]Gormley K, Bevan S, Hassan A, et al. Polymorphisms in genes of the endothelin system and cerebral small-vessel disease[J]. Stroke.2005,36(8): 1656-1660.
[39]d'Uscio LV, Barton M, Shaw S, et al. Endothelin in atherosclerosis: importance of risk factors and therapeutic implications[J]. J Cardiovasc Pharmacol.2000,35(4 Suppl 2):S55-59.
[1]Brainin M, Teuschl Y, Kalra L. Acute treatment and long-term management of stroke in developing countries[J]. Lancet Neurol.2007,6(6):553-561.
[2]Liu M, Wu B, Wang WZ, et al. Stroke in China:epidemiology, prevention, and management strategies[J]. Lancet Neurol.2007,6(5):456-464.
[3]Yang QD, Niu Q, Zhou YH, et al. Incidence of cerebral hemorrhage in the Changsha community. A prospective study from 1986 to 2000[J]. Cerebrovasc Dis.2004,17(4):303-313.
[4]Dichgans M. Genetics of ischaemic stroke[J]. Lancet Neurol.2007,6(2): 149-161.
[5]Greenberg RS, R.Daniels S, Flanders WD. Medical Epidemiology [J].2006: 171-182.
[6]张成.再论重视脑血管病的遗传学研究[J].中国现代神经疾病杂志.2008,8(2)：99-104.
[7]Brass LM, Isaacsohn JL, Merikangas KR, et al. A study of twins and stroke[J]. Stroke.1992,23(2):221-223.
[8]Bak S, Gaist D, Sindrup SH, et al. Genetic liability in stroke:a long-term follow-up study of Danish twins[J]. Stroke.2002,33(3):769-774.
[9]Kiely DK, Wolf PA, Cupples LA, et al. Familial aggregation of stroke. The Framingham Study[J]. Stroke.1993,24(9):1366-1371.
[10]Liao D, Myers R, Hunt S, et al. Familial history of stroke and stroke risk. The Family Heart Study[J]. Stroke.1997,28(10):1908-1912.
[11]Schulz UG, Flossmann E, Rothwell PM. Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies[J]. Stroke.2004,35(4):819-824.
[12]Baron M. Optimal ascertainment strategies to detect linkage to common disease alleles[J]. Am J Hum Genet.1999,64(4):1243-1248.
[13]Gretarsdottir S, Sveinbjornsdottir S, Jonsson HH, et al. Localization of a susceptibility gene for common forms of stroke to 5ql2[J]. Am J Hum Genet. 2002,70(3):593-603.
[14]Meschia JF, Brott TG, Brown RD, Jr., et al. Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke[J]. Ann Neurol.2005,58(3): 351-361.
[15]Gretarsdottir S, Thorleifsson G, Reynisdottir ST, et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke[J]. Nat Genet.2003,35(2): 131-138.
[16]Rosand J, Bayley N, Rost N, et al. Many hypotheses but no replication for the association between PDE4D and stroke[J]. Nat Genet.2006,38(10):1091-1092; author reply 1092-1093.
[17]Woo D, Kaushal R, Kissela B, et al. Association of Phosphodiesterase 4D with ischemic stroke:a population-based case-control study[J]. Stroke.2006,37(2): 371-376.
[18]Nakayama T, Asai S, Sato N, et al. Genotype and haplotype association study of the STRK1 region on 5q12 among Japanese:a case-control study[J]. Stroke. 2006,37(1):69-76.
[19]Saleheen D, Bukhari S, Haider SR, et al. Association of phosphodiesterase 4D gene with ischemic stroke in a Pakistani population[J]. Stroke.2005,36(10): 2275-2277.
[20]van Rijn MJ, Slooter AJ, Schut AF, et al. Familial aggregation, the PDE4D gene, and ischemic stroke in a genetically isolated population[J]. Neurology. 2005,65(8):1203-1209.
[21]Kuhlenbaumer G, Berger K, Huge A, et al. Evaluation of single nucleotide polymorphisms in the phosphodiesterase 4D gene (PDE4D) and their association with ischaemic stroke in a large German cohort[J]. J Neurol Neurosurg Psychiatry.2006,77(4):521-524.
[22]Nilsson-Ardnor S, Wiklund PG, Lindgren P, et al. Linkage of ischemic stroke to the PDE4D region on 5q in a Swedish population[J]. Stroke.2005,36(8): 1666-1671.
[23]Bevan S, Porteous L, Sitzer M, et al. Phosphodiesterase 4D gene, ischemic stroke, and asymptomatic carotid atherosclerosis[J]. Stroke.2005,36(5): 949-953.
[24]Lohmussaar E, Gschwendtner A, Mueller JC, et al. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients[J]. Stroke.2005, 36(4):731-736.
[25]Kostulas K, Gretarsdottir S, Kostulas V, et al. PDE4D and ALOX5AP genetic variants and risk for Ischemic Cerebrovascular Disease in Sweden[J]. J Neurol Sci.2007,263(1-2):113-117.
[26]Fidani L, Clarimon J, Goulas A, et al. Association of phosphodiesterase 4D gene GO haplotype and ischaemic stroke in a Greek population[J]. Eur J Neurol. 2007,14(7):745-749.
[27]Staton JM, Sayer MS, Hankey GJ, et al. Association between phosphodiesterase 4D gene and ischaemic stroke[J]. J Neurol Neurosurg Psychiatry.2006,77(9):1067-1069.
[28]Song Q, Cole JW, O'Connell JR, et al. Phosphodiesterase 4D polymorphisms and the risk of cerebral infarction in a biracial population:the Stroke Prevention in Young Women Study[J]. Hum Mol Genet.2006,15(16):2468-2478.
[29]Zee RY, Brophy VH, Cheng S, et al. Polymorphisms of the phosphodiesterase 4D, cAMP-specific (PDE4D) gene and risk of ischemic stroke:a prospective, nested case-control evaluation[J]. Stroke.2006,37(8):2012-2017.
[30]Brophy VH, Ro SK, Rhees BK, et al. Association of phosphodiesterase 4D polymorphisms with ischemic stroke in a US population stratified by hypertension status[J]. Stroke.2006,37(6):1385-1390.
[31]Nilsson-Ardnor S, Wiklund PG, Lindgren P, et al. Linkage of ischemic stroke to the PDE4D region on 5q in a Swedish population[J]. Stroke.2005,36(8): 1666-1671.
[32]Staton JM, Sayer MS, Hankey GJ, et al. Association between phosphodiesterase 4D gene and ischaemic stroke[J]. Journal of neurology, neurosurgery, and psychiatry.2006,77(9):1067-1069.
[33]Helgadottir A, Manolescu A, Thorleifsson G, et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke[J]. Nat Genet.2004,36(3):233-239.
[34]Dixon RA, Diehl RE, Opas E, et al. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis[J]. Nature.1990, 343(6255):282-284.
[35]Shen CD, Zhang WL, Sun K, et al. Interaction of genetic risk factors confers higher risk for thrombotic stroke in male Chinese:a multicenter case-control study[J]. Ann Hum Genet.2007,71(Pt 5):620-629.
[36]Kaushal R, Pal P, Alwell K, et al. Association of ALOX5AP with ischemic stroke:a population-based case-control study[J]. Hum Genet.2007,121(5): 601-607.
[37]Zhang WL, Yang XM, Shi J, et al. Polymorphism of SG13S114T/A in the ALOX5AP gene and the risk for stroke in a large Chinese cohort[J]. Yi Chuan Xue Bao.2006,33(8):678-684.
[38]Kajimoto K, Shioji K, Ishida C, et al. Validation of the association between the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a Japanese population[J]. Circ J.2005,69(9):1029-1034.
[39]Helgadottir A, Gretarsdottir S, St Clair D, et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population[J]. Am J Hum Genet.2005,76(3):505-509.
[40]Zee RY, Cheng S, Hegener HH, et al. Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke:a nested case-control approach[J]. Stroke.2006,37(8): 2007-2011.
[41]Nilsson-Ardnor S, Janunger T, Wiklund PG, et al. Genome-wide linkage scan of common stroke in families from northern Sweden[J]. Stroke.2007,38(1): 34-40.
[42]Rosand J, Altshuler D. Human genome sequence variation and the search for genes influencing stroke[J]. Stroke.2003,34(10):2512-2516.
[43]Woo D, Kaushal R, Chakraborty R, et al. Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage [J]. Stroke.2005,36(9):1874-1879.
[44]Woo D, Sekar P, Chakraborty R, et al. Genetic epidemiology of intracerebral hemorrhage[J]. J Stroke Cerebrovasc Dis.2005,14(6):239-243.
[45]Kaushal R, Woo D, Pal P, et al. Subarachnoid hemorrhage:tests of association with apolipoprotein E and elastin genes[J]. BMC Med Genet.2007,8:49.
[46]Gould DB, Phalan FC, van Mil SE, et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke[J]. N Engl J Med.2006,354(14):1489-1496.
[47]Alberts MJ, Davis JP, Graffagnino C, et al. Endoglin gene polymorphism as a risk factor for sporadic intracerebral hemorrhage [J]. Ann Neurol.1997,41(5): 683-686.
[48]Catto AJ, Kohler HP, Bannan S, et al. Factor XIII Val 34 Leu:a novel association with primary intracerebral hemorrhage [J]. Stroke.1998,29(4): 813-816.
[49]Gemmati D, Serino ML, Ongaro A, et al. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu):a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases[J]. Am J Hematol. 2001,67(3):183-188.
[50]Slowik A, Turaj W, Dziedzic T, et al. DD genotype of ACE gene is a risk factor for intracerebral hemorrhage [J]. Neurology.2004,63(2):359-361.
[51]Nadel JA. Genetics reveals importance of platelet activating factor in asthma and possibly other inflammatory states[J]. J Clin Invest.1996,97(12): 2689-2690.
[52]Navarro-Nunez L, Lozano ML, Rivera J, et al. The association of the betal-tubulin Q43P polymorphism with intracerebral hemorrhage in men[J]. Haematologica.2007,92(4):513-518.
[53]Banerjee I, Gupta V, Ganesh S. Association of gene polymorphism with genetic susceptibility to stroke in Asian populations:A meta-analysis[J]. Journal of Human Genetics.2007,52(3):205-219.
[54]Xu X, Li J, Sheng W, et al. Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population[J]. Cerebrovasc Dis.2008,26(1):48-62.
[55]Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration[J]. Science.2005,308(5720):385-389.
[56]Herbert A, Gerry NP, McQueen MB, et al. A common genetic variant is associated with adult and childhood obesity[J]. Science.2006,312(5771): 279-283.
[57]Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity[J]. Science.2007,316(5826):889-894.
[58]Saxena R, Voight BF, Lyssenko V, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels [J]. Science.2007, 316(5829):1331-1336.
[59]Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants[J]. Science. 2007,316(5829):1341-1345.
[60]Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease[J]. N Engl J Med.2007,357(5):443-453.
[61]严卫丽.复杂疾病全基因组关联研究进展-研究设计和遗传标记[J].遗传.2008,30(4)：400-406.
[62]Matarin M, Brown WM, Scholz S, et al. A genome-wide genotyping study in patients with ischaemic stroke:initial analysis and data release[J]. Lancet Neurol. 2007,6(5):414-420.
[63]Kubo M, Hata J, Ninomiya T, et al. A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction [J]. Nat Genet.2007, 39(2):212-217.
[64]Cupples LA, Arruda HT, Benjamin EJ, et al. The Framingham Heart Study 100K SNP genome-wide association study resource:overview of 17 phenotype working group reports[J]. BMC Med Genet.2007,8 Suppl 1:S1.
[65]Larson MG, Atwood LD, Benjamin EJ, et al. Framingham Heart Study 100K project:genome-wide associations for cardiovascular disease outcomes[J]. BMC Med Genet.2007,8 Suppl 1:S5.
[66]McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease[J]. Science.2007, 316(5830):1488-1491.
[67]Simon-Sanchez J, Singleton A. Genome-wide association studies in neurological disorders[J]. Lancet Neurology.2008,7(11):1067-1072.
[68]Dorningues-Montanari S, Mendioroz M, del Rio-Espinola A, et al. Genetics of stroke:a review of recent advances[J]. Expert Review of Molecular Diagnostics. 2008,8(4):495-513.
[69]Huang Q, Liu YH, Yang QD, et al. Human serum paraoxonase gene polymorphisms, Q192R and L55M, are not associated with the risk of cerebral infarction in Chinese Han population[J]. Neurol Res.2006,28(5):549-554.
[70]Xia J, Yuan M, Xu HW, et al. Association between Val/Leu(247) polymorphism of apolipoprotein H and cerebral infarction in a Chinese population[J]. J Thromb Thrombolysis.2008.
[71]胡中扬,张乐,杨期东,等.ApoB基因多态性与长沙汉族人群脑出血的关系及其对血脂水平的影响[J].中南大学学报：医学版.2008,33(6)：494-499.
[72]夏健,杨期东,杨期明,等.载脂蛋白H基因7号外显子多态性与长沙地区汉族人脑卒中的相关性[J].中华神经科杂志.2003,36(4)：256-260.
[73]张乐,杨期东.载脂蛋白B基因多态性与动脉粥样硬化性疾病[J].国外医学：神经病学.神经外科学分册.2003,30(5)：450-453.
[74]张乐,杨期东,曾艺,等.载脂蛋白B基因C7673T突变与有家族聚集现象脑梗死的关系[J].中华神经科杂志.2005,38(12)：784-785.
[75]张乐,曾艺,杨期东,等.载脂蛋白B基因G11039A多态与脑血管病的关系研究[J].实用预防医学.2005,12(4)：807-810.
[76]张乐,曾艺,杨期东,等.载脂蛋白b基因3'-VNTR多态与长沙地区脑血管病的关系研究[J].实用预防医学.2005,12(1)：57-59.
[77]Zhang L, Yang QD, Zeng Y. Positive association of apolipoprotein B gene C7673T polymorphism with cerebral hemorrhage with family history [J]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi.2008,25(2):145-149.
[78]Xia J, Yang QD, Yang QM, et al. Apolipoprotein H gene polymorphisms and risk of primary cerebral hemorrhage in a Chinese population[J]. Cerebrovasc Dis. 2004,17(2-3):197-203.
[2]Woo, D.,Sauerbeck, L. R.,Kissela, B. M., et al. Genetic and environmental risk factors for intracerebral hemorrhage:preliminary results of a population-based study[J]. Stroke,2002,33(5):1190-5.
[3]Sessa, M. Intracerebral hemorrhage and hypertension[J]. Neurol Sci,2008,29 Suppl 2:S258-9.
[4]Hanggi, D.,Steiger, H. J. Spontaneous intracerebral haemorrhage in adults:a literature overview[J]. Acta Neurochir (Wien),2008,150(4):371-9; discussion 379.
[5]Elijovich, L.,Patel, P. V.,Hemphill, J. C.,3rd. Intracerebral hemorrhage[J]. Semin Neurol,2008,28(5):657-67.
[6]Sturgeon, J. D.,Folsom, A. R.,Longstreth, W. T., Jr., et al. Risk factors for intracerebral hemorrhage in a pooled prospective study[J]. Stroke,2007,38(10): 2718-25.
[7]Ariesen, M. J.,Claus, S. P.,Rinkel, G. J., et al. Risk factors for intracerebral hemorrhage in the general population:a systematic review[J]. Stroke,2003, 34(8):2060-5.
[8]Yang, Q. D.,Niu, Q.,Zhou, Y. H., et al. Incidence of cerebral hemorrhage in the Changsha community. A prospective study from 1986 to 2000[J]. Cerebrovasc Dis,2004,17(4):303-13.
[9]Fisher, C. M. Pathological observations in hypertensive cerebral hemorrhage [J]. J Neuropathol Exp Neurol,1971,30(3):536-50.
[10]Manno, E. M.,Atkinson, J. L.,Fulgham, J. R., et al. Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage[J]. Mayo Clin Proc,2005,80(3):420-33.
[11]Tamaki, T.,Oyama, K.,Uematsu, M., et al. [An ultrasonic study of the relationship between extracranial carotid atherosclerosis and intracerebral hemorrhage][J]. No Shinkei Geka,2000,28(2):147-52.
[12]Mazighi, M.,Labreuche, J.,Gongora-Rivera, F., et al. Autopsy prevalence of proximal extracranial atherosclerosis in patients with fatal stroke [J]. Stroke,2009,40(3):713-8.
[13]Inagawa, T. Risk factors for primary intracerebral hemorrhage in patients in Izumo City, Japan[J]. Neurosurg Rev,2007,30(3):225-34; discussion 234.
[14]Zhou, J. F.,Wang, J. Y.,Luo, Y. E., et al. Influence of hypertension, lipometabolism disorders, obesity and other lifestyles on spontaneous intracerebral hemorrhage [J]. Biomed Environ Sci,2003,16(3):295-303.
[15]刘宝琼.长沙汉族人群VLDL/LDL代谢途径相关基因多态性与脑出血的关系研究：[博士学位论文].长沙：中南大学,2009
[16]Dickinson, C. J. Why are strokes related to hypertension? Classic studies and hypotheses revisited[J].J Hypertens,2001,19(9):1515-21.
[17]Yanagisawa, M.,Kurihara, H.,Kimura, S., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells[J]. Nature,1988,332(6163): 411-5.
[18]Inoue, A.,Yanagisawa, M.,Kimura, S., et al. The human endothelin family:three structurally and pharmacologically distinct isopeptides predicted by three separate genes[J]. Proc Natl Acad Sci U S A,1989,86(8):2863-7.
[19]von Websky, K.,Heiden, S.,Pfab, T., et al. Pathophysiology of the endothelin system-lessons from genetically manipulated animal models[J]. Eur J Med Res,2009,14(1):1-6.
[20]Rubanyi, G. M.,Polokoff, M. A. Endothelins:molecular biology, biochemistry, pharmacology, physiology, and pathophysiology [J]. Pharmacol Rev,1994,46(3): 325-415.
[21]Garncarczyk, A.,Jurzak, M.,Gojniczek, K. [Characteristic of the endogenous peptides-endothelins and their role in the connective tissue fibrosis][J]. Wiad Lek,2008,61(4-6):126-34.
[22]Sorrentino, S.,Forleo, C.,Iacoviello, M., et al. Endothelin system polymorphisms in tilt test-induced vasovagal syncope[J]. Clin Auton Res,2009.
[23]Schiffrin, E. L. Role of endothelin-1 in hypertension and vascular disease[J]. Am J Hypertens,2001,14(6 Pt 2):83S-89S.
[24]Shichiri, M.,Hirata, Y.,Ando, K., et al. Plasma endothelin levels in hypertension and chronic renal failure[J]. Hypertension,1990,15(5):493-6.
[25]Shreenivas, S.,Oparil, S. The role of endothelin-1 in human hypertension[J]. Clin Hemorheol Microcirc,2007,37(1-2):157-78.
[26]Taddei, S.,Virdis, A.,Ghiadoni, L., et al. Role of endothelin in the control of peripheral vascular tone in human hypertension[J]. Heart Fail Rev,2001,6(4): 277-85.
[27]Schneider, M. P.,Boesen, E. I.,Pollock, D. M. Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease[J]. Annu Rev Pharmacol Toxicol,2007,47:731-59.
[28]Roquer, J.,Segura, T.,Serena, J., et al. Endothelial dysfunction, vascular disease and stroke:the ARTICO study[J]. Cerebrovasc Dis,2009,27 Suppl 1:25-37.
[29]Edvinsson, L. Cerebrovascular endothelin receptor upregulation in cerebral ischemia[J]. Curr Vasc Pharmacol,2009,7(1):26-33.
[30]Giannopoulos, S.,Kosmidou, M.,Hatzitolios, A. I., et al. Measurements of endothelin-1, C-reactive protein and fibrinogen plasma levels in patients with acute ischemic stroke[J]. Neurol Res,2008,30(7):727-30.
[31]Moldes, O.,Sobrino, T.,Millan, M., et al. High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA[J]. Stroke,2008,39(7):2006-10.
[32]Ivey, M. E.,Osman, N.,Little, P. J. Endothelin-1 signalling in vascular smooth muscle:pathways controlling cellular functions associated with atherosclerosis [J]. Atherosclerosis,2008,199(2):237-47.
[33]张微微,黄勇华.脑出血患者脑反应性星形细胞内皮素-1的表达[J].中国神经精神疾病杂志,2001,27(1)：41-42.
[34]赵永波,王忠卿.血浆内皮素水平变化及其临床意义[J].临床神经病学杂志,2002,15(6)：361-362.
[35]李永强,郑玉明,刘立华.脑出血患者内皮素与血肿周围脑水肿形成关系的研究[J].临床医药实践,2006,15(9)：674-675.
[36]武婕,章柏松.ET和NO在脑出血中的变化以及硫酸镁的干预作用[J].中国血液流变学杂志,2004,14(1)：32-36.
[37]MacClellan, L. R.,Howard, T. D.,Cole, J. W., et al. Relation of candidate genes that encode for endothelial function to migraine and stroke:the Stroke Prevention in Young Women study[J]. Stroke,2009,40(10):e550-7.
[38]Lacolley, P.,Challande, P.,Osborne-Pellegrin, M., et al. Genetics and pathophysiology of arterial stiffness[J]. Cardiovasc Res,2009,81(4):637-48.
[39]Rahman, T.,Baker, M.,Hall, D. H., et al. Common genetic variation in the type A endothelin-1 receptor is associated with ambulatory blood pressure:a family study[J]. J Hum Hypertens,2008,22(4):282-8.
[40]Popov, A. F.,Schulz, E. G.,Hinz, J., et al. Impact of endothelin-1 Lys198Asn polymorphism on coronary artery disease and endorgan damage in hypertensives[J]. Coron Artery Dis,2008,19(7):429-34.
[41]Panoulas, V. F.,Douglas, K. M.,Smith, J. P., et al. Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis[J]. Endothelium,2008,15(4):203-12.
[42]Lee, J.,Cheong, S. S.,Kim, J. Association of endothelin-1 gene polymorphisms with variant angina in Korean patients[J]. Clin Chem Lab Med,2008,46(11): 1575-80.
[43]Schiffrin, E. L.,Deng, L. Y.,Sventek, P., et al. Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension[J]. J Hypertens,1997,15(1):57-63.
[44]Tiret, L.,Poirier, O.,Hallet, V., et al. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people[J]. Hypertension,1999,33(5):1169-74.
[45]Asai, T.,Ohkubo, T.,Katsuya, T., et al. Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects:the Ohasama Study [J]. Hypertension,2001,38(6):1321-4.
[46]Barath, A.,Endreffy, E.,Bereczki, C., et al. Endothelin-1 gene and endothelial nitric oxide synthase gene polymorphisms in adolescents with juvenile and obesity-associated hypertension[J]. Acta Physiol Hung,2007,94(1-2):49-66.
[47]汤旭磊.内皮素受体研究进展[J].兰州医学院学报,2000,26(1)：58-61.
[48]Treiber, F. A.,Barbeau, P.,Harshfield, G., et al. Endothelin-1 gene Lys198Asn polymorphism and blood pressure reactivity [J]. Hypertension,2003,42(4): 494-9.
[49]Banno, M.,Hanada, H.,Kamide, K., et al. Association of genetic polymorphisms of endothelin-converting enzyme-1 gene with hypertension in a Japanese population and rare missense mutation in preproendothelin-1 in Japanese hypertensives[J]. Hypertens Res,2007,30(6):513-20.
[50]Nicaud, V.,Poirier, O.,Behague, I., et al. Polymorphisms of the endothelin-A and-B receptor genes in relation to blood pressure and myocardial infarction:the Etude Cas-Temoins sur l'Infarctus du Myocarde (ECTIM) Study [J]. Am J Hypertens,1999,12(3):304-10.
[51]Funalot, B.,Courbon, D.,Brousseau, T., et al. Genes encoding endothelin-converting enzyme-1 and endothelin-1 interact to influence blood pressure in women:the EVA study[J]. J Hypertens,2004,22(4):739-43.
[52]Tanaka, C.,Kamide, K.,Takiuchi, S., et al. Evaluation of the Lys198Asn and-134delA genetic polymorphisms of the endothelin-1 gene[J]. Hypertens Res,2004,27(5):367-71.
[53]Caprioli, J.,Mele, C.,Mossali, C., et al. Polymorphisms of EDNRB, ATG, and ACE genes in salt-sensitive hypertension[J]. Can J Physiol Pharmacol,2008, 86(8):505-10.
[54]Lajemi, M.,Gautier, S.,Poirier, O., et al. Endothelin gene variants and aortic and cardiac structure in never-treated hypertensives [J]. Am J Hypertens,2001,14(8 Pt 1):755-60.
[55]Yasuda, H.,Kamide, K.,Takiuchi, S., et al. Association of single nucleotide polymorphisms in endothelin family genes with the progression of atherosclerosis in patients with essential hypertension[J]. J Hum Hypertens,2007,21(11):883-92.
[56]Jin, Z.,Luxiang, C.,Huadong, Z., et al. C-338A polymorphism of the endothelin-converting enzyme-1 gene and the susceptibility to carotid atherosclerosis[J]. Microvasc Res,2009.
[57]Kozak, M.,Holla, L. I.,Krivan, L., et al. Endothelin-1 gene polymorphism in the identification of patients at risk for malignant ventricular arrhythmia[J]. Med Sci Monit,2002,8(5):BR164-7.
[58]Buhler, K.,Ufer, M.,Muller-Marbach, A., et al. Risk of coronary artery disease as influenced by variants of the human endothelin and endothelin-converting enzyme genes[J]. Pharmacogenet Genomics,2007,17(1):77-83.
[59]Wang, L. S.,Tang, N. P.,Zhu, H. J., et al. Endothelin-converting enzyme-lb C-338A polymorphism is associated with the increased risk of coronary artery disease in Chinese population[J]. Clin Chim Acta,2007,384(1-2):75-9.
[60]Gormley, K.,Bevan, S.,Hassan, A., et al. Polymorphisms in genes of the endothelin system and cerebral small-vessel disease[J]. Stroke,2005,36(8): 1656-60.
[61]张乐,杨期东,曾艺,等.载脂蛋白B基因C7673T多态与有家族聚集现象脑出血的关[J].中华医学遗传学杂志,2008,25(2)：145-149.
[62]刘宝琼,张乐,杨期东,等.载脂蛋白B基因3’-VNTR多态性与家族聚集性脑出血的关系[J].中国神经精神疾病杂志,2009,35(5)：269-273.
[63]胡中扬,张乐,杨期东,等.APOB基因G11039A多态性与家族聚集性脑出血的相关性研究[J].卒中与神经疾病,2008,15(05)：268-272.
[64]Fischer, C.,Beckmann, L.,Majoram, P., et al. Haplotype sharing analysis with SNPs in candidate genes:the Genetic Analysis Workshop 12 example[J]. Genet Epidemiol,2003,24(1):68-73.
[65]Schork, N. J.,Fallin, D.,Lanchbury, J. S. Single nucleotide polymorphisms and the future of genetic epidemiology [J]. Clin Genet,2000,58(4):250-64.
[66]Hirschhorn, J. N.,Lohmueller, K.,Byrne, E., et al. A comprehensive review of genetic association studies[J]. Genet Med,2002,4(2):45-61.
[67]Salisbury, B. A.,Pungliya, M.,Choi, J. Y., et al. SNP and haplotype variation in the human genome[J]. Mutat Res,2003,526(1-2):53-61.
[68]Li, J.,Pan, Y. C.,Li, Y. X., et al. [Analysis and application of SNP and haplotype in the human genome][J]. Yi Chuan Xue Bao,2005,32(8):879-89.
[69]Palmer, L. J.,Cardon, L. R. Shaking the tree:mapping complex disease genes with linkage disequilibrium[J]. Lancet,2005,366(9492):1223-34.
[70]马明明,张乐,杨期东.脑卒中的遗传学研究策略及研究进展[J].中华神经科杂志,2009,42(12)：849-851.
[71]Laird, N. M.,Lange, C. Family-based designs in the age of large-scale gene-association studies[J]. Nat Rev Genet,2006,7(5):385-94.
[72]Sacco, R.,Papaleo, V.,Hager, J., et al. Case-control and family-based association studies of candidate genes in autistic disorder and its endophenotypes:TPH2 and GLO1[J]. BMC Med Genet,2007,8:11.
[73]Davenport, A. P.,Maguire, J. J. Endothelin[J]. Handb Exp Pharmacol,2006, (176 Pt 1):295-329.
[74]d'Uscio, L. V.,Barton, M.,Shaw, S., et al. Endothelin in atherosclerosis: importance of risk factors and therapeutic implications [J]. J Cardiovasc Pharmacol,2000,35(4 Suppl 2):S55-59.
[75]Brunner, F.,Bras-Silva, C.,Cerdeira, A. S., et al. Cardiovascular endothelins: essential regulators of cardiovascular homeostasis[J]. Pharmacol Ther,2006, 111(2):508-31.
[76]Shah, R. Endothelins in health and disease[J]. Eur J Intern Med,2007,18(4): 272-82.
[77]Bousette, N.,Giaid, A. Endothelin-1 in atherosclerosis and other vasculopathies[J]. Can J Physiol Pharmacol,2003,81(6):578-87.
[78]阎瑛,黄锦华.血浆内皮素(ET)对脑出血、癫痫诊断价值的探讨[J].2005,16(1)：149-150.
[79]Lee, M. E.,Bloch, K. D.,Clifford, J. A., et al. Functional analysis of the endothelin-1 gene promoter. Evidence for an endothelial cell-specific cis-acting sequence[J]. J Biol Chem,1990,265(18):10446-50.
[80]Jin, J. J.,Nakura, J.,Wu, Z., et al. Association of endothelin-1 gene variant with hypertension[J]. Hypertension,2003,41(1):163-7.
[81]Nauck, M.,Warnick, G. R.,Rifai, N. Methods for measurement of LDL-cholesterol:a critical assessment of direct measurement by homogeneous assays versus calculation [J]. Clin Chem,2002,48(2):236-54.
[82]Rost, N. S.,Greenberg, S. M.,Rosand, J. The genetic architecture of intracerebral Hemorrhage[J]. Stroke,2008,39(7):2166-2173.
[83]McPherson, R.,Pertsemlidis, A.,Kavaslar, N., et al. A common allele on chromosome 9 associated with coronary heart disease[J]. Science,2007, 316(5830):1488-91.
[84]Haines, J. L.,Pericak-Vance, M. A. Rapid dissection of the genetic risk of age-related macular degeneration:achieving the promise of the genomic era[J]. JAMA,2007,297(4):401-2.
[85]Saxena, R.,Voight, B. F.,Lyssenko, V., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels [J]. Science,2007, 316(5829):1331-6.
[86]Hampe, J.,Franke, A.,Rosenstiel, P., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1[J]. Nat Genet,2007,39(2):207-11.
[87]Hafler, D. A.,Compston, A.,Sawcer, S., et al. Risk alleles for multiple sclerosis identified by a genomewide study[J]. N Engl J Med,2007,357(9):851-62.
[88]Matarin, M.,Brown, W. M.,Scholz, S., et al. A genome-wide genotyping study in patients with ischaemic stroke:initial analysis and data release[J]. Lancet Neurol,2007,6(5):414-20.
[89]张学军.复杂疾病的遗传学研究策略[J].安徽医科大学学报,2007,42(3)：237-240.
[90]Alberts, M. J.,McCarron, M. O.,Hoffmann, K. L., et al. Familial clustering of intracerebral hemorrhage:a prospective study in North Carolina[J]. Neuroepidemiology,2002,21(1):18-21.
[91]Kiely, D. K.,Wolf, P. A.,Cupples, L. A., et al. Familial aggregation of stroke. The Framingham Study[J]. Stroke,1993,24(9):1366-71.
[92]Feigin, V. L. Stroke epidemiology in the developing world[J]. Lancet,2005, 365(9478):2160-1.
[93]胡中扬,张乐,杨期东等.ApoB基因多态性与长沙汉族人群脑出血的关系及其对血脂水平的影响[J].中南大学学报：医学版,2008,33(6)：494-499.
[94]Woo, D.,Sekar, P.,Chakraborty, R., et al. Genetic epidemiology of intracerebral hemorrhage[J]. J Stroke Cerebrovasc Dis,2005,14(6):239-43.
[95]Rosand, J.,Altshuler, D. Human genome sequence variation and the search for genes influencing stroke[J]. Stroke,2003,34(10):2512-6.
[96]Wityk, R. J.,Caplan, L. R. Hypertensive intracerebral hemorrhage. Epidemiology and clinical pathology[J]. Neurosurg Clin N Am,1992,3(3): 521-32.
[97]He, J.,Klag, M. J.,Wu, Z., et al. Stroke in the People's Republic of China. I. Geographic variations in incidence and risk factors[J]. Stroke,1995,26(12): 2222-7.
[98]黄勇华,张微微,郝小淑.内皮素与中枢神经系统疾病[J].北京医学,2000,22(1)：43-45.
[99]李丽华,赵炳让.内皮素-1基因多态性及其与高血压的关系[J].医学综述,2008,14(17)：2595-2597.
[100]Schweizer, A.,Valdenaire, O.,Nelbock, P., et al. Human endothelin-converting enzyme (ECE-1):three isoforms with distinct subcellular localizations [J]. Biochem J,1997,328 (Pt 3):871-7.
[101]吴孟津,廖端芳,彭翠英,等.湖南娄底地区汉族人群内皮素基因rs5370G/T多态性研究[J].实用预防医学,2007,14(3)：620-622.
[102]Zhu, G.,Carlsen, K.,Carlsen, K. H., et al. Polymorphisms in the endothelin-1 (EDN1) are associated with asthma in two populations [J]. Genes Immun,2008, 9(1):23-9.
[103]Miyata, S.,Ohhata, N.,Murai, H., et al. WS009 A and B, new endothelin receptor antagonists isolated from Streptomyces sp. no.89009. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities [J]. J Antibiot (Tokyo),1992,45(7):1029-40.
[104]Imokawa, G.,Yada, Y.,Kimura, M. Signalling mechanisms of endothelin-induced mitogenesis and melanogenesis in human melanocytes[J]. Biochem J,1996,314 (Pt1):305-12.
[105]Highsmith, R. F.,Pang, D. C.,Rapoport, R. M. Endothelial cell-derived vasoconstrictors:mechanisms of action in vascular smooth muscle[J]. J Cardiovasc Pharmacol,1989,13 Suppl 5:S36-44; discussion S45.
[106]Miyauchi, T.,Ishikawa, T.,Tomobe, Y., et al. Characteristics of pressor response to endothelin in spontaneously hypertensive and Wistar-Kyoto rats[J]. Hypertension,1989,14(4):427-34.
[107]Inagami, T.,Naruse, M.,Hoover, R. Endothelium as an endocrine organ[J]. Annu Rev Physiol,1995,57:171-89.
[108]Halcox, J. P.,Nour, K. R.,Zalos, G, et al. Endogenous endothelin in human coronary vascular function:differential contribution of endothelin receptor types A and B[J]. Hypertension,2007,49(5):1134-41.
[109]Crowley, R. W.,Medel, R.,Kassell, N. F., et al. New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage [J]. Drug Discov Today,2008,13(5-6):254-60.
[110]Iemitsu, M.,Maeda, S.,Otsuki, T., et al. Polymorphism in endothelin-related genes limits exercise-induced decreases in arterial stiffness in older subjects[J]. Hypertension,2006,47(5):928-36.
[111]Levin, E. R. Endothelins[J]. N Engl J Med,1995,333(6):356-63.
[112]Kedzierski, R. M.,Yanagisawa, M. Endothelin system:the double-edged sword in health and disease[J]. Annu Rev Pharmacol Toxicol,2001,41:851-76.
[113]Van Renterghem, C.,Vigne, P.,Barhanin, J., et al. Molecular mechanism of action of the vasoconstrictor peptide endothelin[J]. Biochem Biophys Res Commun,1988,157(3):977-85.
[114]Hirata, Y.,Yoshimi, H.,Takata, S., et al. Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells[J]. Biochem Biophys Res Commun,1988,154(3):868-75.
[115]Mohacsi, A.,Magyar, J.,Tamas, B., et al. Effects of endothelins on cardiac and vascular cells:new therapeutic target for the future?[J]. Curr Vasc Pharmacol,2004,2(1):53-63.
[116]Dhaun, N.,Goddard, J.,Kohan, D. E., et al. Role of endothelin-1 in clinical hypertension:20 years on[J]. Hypertension,2008,52(3):452-9.
[117]Benjafield, A. V.,Katyk, K.,Morris, B. J. Association of EDNRA, but not WNK4 or FKBP1B, polymorphisms with essential hypertension[J]. Clin Genet,2003, 64(5):433-8.
[118]Colombo, M. G.,Ciofini, E.,Paradossi, U., et al. ET-1 Lys198Asn and ET(A) receptor H323H polymorphisms in heart failure. A case-control study[J]. Cardiology,2006,105(4):246-52.
[119]Tzourio, C.,E1 Amrani, M.,Poirier, O., et al. Association between migraine and endothelin type A receptor (ETA-231 A/G) gene polymorphism [J]. Neurology,2001,56(10):1273-7.
[120]李丽华,赵炳让.内皮素-1基因Lysl98Asn及TaqI多态性与原发性高血压关系的研究[J].中国分子心脏病学杂志,2008,8(3)：165-169.
[121]吕晔,于东.血浆内皮素1与高血压脑出血的关系[J].中国综合临床,2004,20(9)：781-782.
[122]Pinet, F. [What is the role of endothelin system?][J]. Med Sci (Paris),2004, 20(3):339-45.
[123]Doggrell, S. A. The endothelin system and its role in acute myocardial infarction[J]. Expert Opin Ther Targets,2004,8(3):191-201.
[124]Reid, K.,Turnley, A. M.,Maxwell, G. D., et al. Multiple roles for endothelin in melanocyte development:regulation of progenitor number and stimulation of differentiation[J]. Development,1996,122(12):3911-9.
[125]Hynynen, M. M.,Khalil, R. A. The vascular endothelin system in hypertension-recent patents and discoveries [J]. Recent Pat Cardiovasc Drug Discov,2006,1(1):95-108.
[126]Jasmin, J. F.,Dupuis, J. Evaluation of luminal endothelin-converting enzyme activity in the pulmonary and coronary circulations [J]. J Cardiovasc Pharmacol,2004,43(1):21-5.
[127]Turner, A. J.,Murphy, L. J. Molecular pharmacology of endothelin converting enzymes[J]. Biochem Pharmacol,1996,51(2):91-102.
[128]杨波,江本宪昭,中山和彦.ECE-1基因敲除小鼠RAAS系统激活及其意义[J].心血管康复医学杂志,2007,16(6)：534-536.
[129]Ihling, C.,Bohrmann, B.,Schaefer, H. E., et al. Endothelin-1 and endothelin converting enzyme-1 in human atherosclerosis-novel targets for pharmacotherapy in atherosclerosis[J]. Curr Vasc Pharmacol,2004,2(3):249-58.
[130]Scacchi, R.,Gambina, G.,Broggio, E., et al. C-338A polymorphism of the endothelin-converting enzyme (ECE-1) gene and the susceptibility to sporadic late-onset Alzheimer's disease and coronary artery disease[J]. Disease Markers,2008,24(3):175-179.
[1]Penna C, Rastaldo R, Mancardi D, et al. Effect of endothelins on the cardiovascular system[J]. J Cardiovasc Med (Hagerstown).2006,7(9):645-652.
[2]Iglarz M, Clozel M. Mechanisms of ET-1-induced endothelial dysfunction[J]. J Cardiovasc Pharmacol.2007,50(6):621-628.
[3]Caprioli J, Mele C, Mossali C, et al. Polymorphisms of EDNRB, ATG, and ACE genes in salt-sensitive hypertension[J]. Can J Physiol Pharmacol.2008, 86(8):505-510.
[4]Arjomand-Nahad F, Landt O, Stangl K, et al. Fifteen polymorphisms in endothelin-1, endothelin-2 and endothelin-receptor-A genotyped by four duplex assays and seven simple assays on a LightCycler using hybridization probes[J]. Clin Chem Lab Med.2006,44(8):929-932.
[5]Yasuda H, Kamide K, Takiuchi S, et al. Association of single nucleotide polymorphisms in endothelin family genes with the progression of atherosclerosis in patients with essential hypertension[J]. J Hum Hypertens.2007, 21(11):883-892.
[6]Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells[J]. Nature.1988,332(6163): 411-415.
[7]Bohm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease[J]. Cardiovasc Res.2007,76(1):8-18.
[8]Mohacsi A, Magyar J, Tamas B, et al. Effects of endothelins on cardiac and vascular cells:new therapeutic target for the future?[J]. Curr Vasc Pharmacol. 2004,2(1):53-63.
[9]Gross PM, Zochodne DW, Wainman DS, et al. Intraventricular endothelin-1 uncouples the blood flow:metabolism relationship in periventricular structures of the rat brain:involvement of L-type calcium channels[J]. Neuropeptides.1992, 22(3):155-165.
[10]Zochodne DW, Ho LT, Gross PM. Acute endoneurial ischemia induced by epineurial endothelin in the rat sciatic nerve[J]. Am J Physiol.1992,263(6 Pt 2): H1806-1810.
[11]Andresen J, Shafi NI, Bryan RM, Jr. Endothelial influences on cerebrovascular tone[J]. J Appl Physiol.2006,100(1):318-327.
[12]Shreenivas S, Oparil S. The role of endothelin-1 in human hypertension[J]. Clin Hemorheol Microcirc.2007,37(1-2):157-178.
[13]Miyauchi T, Masaki T. Pathophysiology of endothelin in the cardiovascular system[J]. Annu Rev Physiol.1999,61:391-415.
[14]Ivey ME, Osman N, Little PJ. Endothelin-1 signalling in vascular smooth muscle:pathways controlling cellular functions associated with atherosclerosis [J]. Atherosclerosis.2008,199(2):237-247.
[15]Crowley RW, Medel R, Kassell NF, et al. New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage[J]. Drug Discov Today.2008,13(5-6):254-260.
[16]Giannopoulos S, Kosmidou M, Hatzitolios AI, et al. Measurements of endothelin-1, C-reactive protein and fibrinogen plasma levels in patients with acute ischemic stroke[J]. Neurol Res.2008,30(7):727-730.
[17]Moldes O, Sobrino T, Millan M, et al. High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA[J]. Stroke.2008,39(7):2006-2010.
[18]Fouyas IP, Brennan P, Kelly PA, et al. The role of endothelin in the cerebrovascular response following intracerebral haemorrhage:experimental studies using the endothelin antagonist SB209670[J]. Br J Neurosurg.2008, 22(1):35-39.
[19]张颖,冯加纯.内皮素作用机制及其与脑出血的相关性研究进展[J].神经疾病与精神卫生.2003,3(6)：488-490.
[20]Tiret L, Poirier O, Hallet V, et al. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people[J]. Hypertension.1999,33(5):1169-1174.
[21]Jin JJ, Nakura J, Wu Z, et al. Association of endothelin-1 gene variant with hypertension[J]. Hypertension.2003,41(1):163-167.
[22]Barden AE, Herbison CE, Beilin LJ, et al. Association between the endothelin-1 gene Lys198Asn polymorphism blood pressure and plasma endothelin-1 levels in normal and pre-eclamptic pregnancy [J]. J Hypertens.2001, 19(10):1775-1782.
[23]Banno M, Hanada H, Kamide K, et al. Association of genetic polymorphisms of endothelin-converting enzyme-1 gene with hypertension in a Japanese population and rare missense mutation in preproendothelin-1 in Japanese hypertensives[J]. Hypertens Res.2007,30(6):513-520.
[24]Treiber FA, Barbeau P, Harshfield G, et al. Endothelin-1 gene Lys198Asn polymorphism and blood pressure reactivity [J]. Hypertension.2003,42(4): 494-499.
[25]Funalot B, Courbon D, Brousseau T, et al. Genes encoding endothelin-converting enzyme-1 and endothelin-1 interact to influence blood pressure in women:the EVA study[J]. J Hypertens.2004,22(4):739-743.
[26]Barath A, Endreffy E, Bereczki C, et al. Endothelin-1 gene and endothelial nitric oxide synthase gene polymorphisms in adolescents with juvenile and obesity-associated hypertension[J]. Acta Physiol Hung.2007,94(1-2):49-66.
[27]Panoulas VF, Douglas KM, Smith JP, et al. Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis[J]. Endothelium.2008,15(4):203-212.
[28]Wiltshire S, Powell BL, Jennens M, et al. Investigating the association between K198N coding polymorphism in EDN1 and hypertension, lipoprotein levels, the metabolic syndrome and cardiovascular disease[J]. Hum Genet.2008, 123(3):307-313.
[29]Rahman T, Baker M, Hall DH, et al. Common genetic variation in the type A endothelin-1 receptor is associated with ambulatory blood pressure:a family study[J]. J Hum Hypertens.2008,22(4):282-288.
[30]Kozak M, Holla LI, Krivan L, et al. Endothelin-1 gene polymorphism in the identification of patients at risk for malignant ventricular arrhythmia[J]. Med Sci Monit.2002,8(5):BR164-167.
[31]Buhler K, Ufer M, Muller-Marbach A et al. Risk of coronary artery disease as influenced by variants of the human endothelin and endothelin-converting enzyme genes[J]. Pharmacogenet Genomics.2007,17(1):77-83.
[32]Popov AF, Schulz EG, Hinz J, et al. Impact of endothelin-1 Lys198Asn polymorphism on coronary artery disease and endorgan damage in hypertensives [J]. Coron Artery Dis.2008,19(7):429-434.
[33]Pare G, Serre D, Brisson D, et al. Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol[J]. Am J Hum Genet.2007,80(4):673-682.
[34]Wang LS, Tang NP, Zhu HJ, et al. Endothelin-converting enzyme-lb C-338A polymorphism is associated with the increased risk of coronary artery disease in Chinese population[J]. Clin Chim Acta.2007,384(1-2):75-79.
[35]Jin Z, Luxiang C, Huadong Z, et al. C-338A polymorphism of the endothelin-converting enzyme-1 gene and the susceptibility to carotid atherosclerosis[J]. Microvasc Res.2009.
[36]Bleumink GS, Schut AF, Sturkenboom MC et al. Genetic polymorphisms and heart failure[J]. Genet Med.2004,6(6):465-474.
[37]Colombo MG, Ciofini E, Paradossi U, et al. ET-1 Lys198Asn and ET(A) receptor H323H polymorphisms in heart failure. A case-control study[J]. Cardiology.2006,105(4):246-252.
[38]Gormley K, Bevan S, Hassan A, et al. Polymorphisms in genes of the endothelin system and cerebral small-vessel disease[J]. Stroke.2005,36(8): 1656-1660.
[39]d'Uscio LV, Barton M, Shaw S, et al. Endothelin in atherosclerosis: importance of risk factors and therapeutic implications[J]. J Cardiovasc Pharmacol.2000,35(4 Suppl 2):S55-59.
[1]Brainin M, Teuschl Y, Kalra L. Acute treatment and long-term management of stroke in developing countries[J]. Lancet Neurol.2007,6(6):553-561.
[2]Liu M, Wu B, Wang WZ, et al. Stroke in China:epidemiology, prevention, and management strategies[J]. Lancet Neurol.2007,6(5):456-464.
[3]Yang QD, Niu Q, Zhou YH, et al. Incidence of cerebral hemorrhage in the Changsha community. A prospective study from 1986 to 2000[J]. Cerebrovasc Dis.2004,17(4):303-313.
[4]Dichgans M. Genetics of ischaemic stroke[J]. Lancet Neurol.2007,6(2): 149-161.
[5]Greenberg RS, R.Daniels S, Flanders WD. Medical Epidemiology [J].2006: 171-182.
[6]张成.再论重视脑血管病的遗传学研究[J].中国现代神经疾病杂志.2008,8(2)：99-104.
[7]Brass LM, Isaacsohn JL, Merikangas KR, et al. A study of twins and stroke[J]. Stroke.1992,23(2):221-223.
[8]Bak S, Gaist D, Sindrup SH, et al. Genetic liability in stroke:a long-term follow-up study of Danish twins[J]. Stroke.2002,33(3):769-774.
[9]Kiely DK, Wolf PA, Cupples LA, et al. Familial aggregation of stroke. The Framingham Study[J]. Stroke.1993,24(9):1366-1371.
[10]Liao D, Myers R, Hunt S, et al. Familial history of stroke and stroke risk. The Family Heart Study[J]. Stroke.1997,28(10):1908-1912.
[11]Schulz UG, Flossmann E, Rothwell PM. Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies[J]. Stroke.2004,35(4):819-824.
[12]Baron M. Optimal ascertainment strategies to detect linkage to common disease alleles[J]. Am J Hum Genet.1999,64(4):1243-1248.
[13]Gretarsdottir S, Sveinbjornsdottir S, Jonsson HH, et al. Localization of a susceptibility gene for common forms of stroke to 5ql2[J]. Am J Hum Genet. 2002,70(3):593-603.
[14]Meschia JF, Brott TG, Brown RD, Jr., et al. Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke[J]. Ann Neurol.2005,58(3): 351-361.
[15]Gretarsdottir S, Thorleifsson G, Reynisdottir ST, et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke[J]. Nat Genet.2003,35(2): 131-138.
[16]Rosand J, Bayley N, Rost N, et al. Many hypotheses but no replication for the association between PDE4D and stroke[J]. Nat Genet.2006,38(10):1091-1092; author reply 1092-1093.
[17]Woo D, Kaushal R, Kissela B, et al. Association of Phosphodiesterase 4D with ischemic stroke:a population-based case-control study[J]. Stroke.2006,37(2): 371-376.
[18]Nakayama T, Asai S, Sato N, et al. Genotype and haplotype association study of the STRK1 region on 5q12 among Japanese:a case-control study[J]. Stroke. 2006,37(1):69-76.
[19]Saleheen D, Bukhari S, Haider SR, et al. Association of phosphodiesterase 4D gene with ischemic stroke in a Pakistani population[J]. Stroke.2005,36(10): 2275-2277.
[20]van Rijn MJ, Slooter AJ, Schut AF, et al. Familial aggregation, the PDE4D gene, and ischemic stroke in a genetically isolated population[J]. Neurology. 2005,65(8):1203-1209.
[21]Kuhlenbaumer G, Berger K, Huge A, et al. Evaluation of single nucleotide polymorphisms in the phosphodiesterase 4D gene (PDE4D) and their association with ischaemic stroke in a large German cohort[J]. J Neurol Neurosurg Psychiatry.2006,77(4):521-524.
[22]Nilsson-Ardnor S, Wiklund PG, Lindgren P, et al. Linkage of ischemic stroke to the PDE4D region on 5q in a Swedish population[J]. Stroke.2005,36(8): 1666-1671.
[23]Bevan S, Porteous L, Sitzer M, et al. Phosphodiesterase 4D gene, ischemic stroke, and asymptomatic carotid atherosclerosis[J]. Stroke.2005,36(5): 949-953.
[24]Lohmussaar E, Gschwendtner A, Mueller JC, et al. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients[J]. Stroke.2005, 36(4):731-736.
[25]Kostulas K, Gretarsdottir S, Kostulas V, et al. PDE4D and ALOX5AP genetic variants and risk for Ischemic Cerebrovascular Disease in Sweden[J]. J Neurol Sci.2007,263(1-2):113-117.
[26]Fidani L, Clarimon J, Goulas A, et al. Association of phosphodiesterase 4D gene GO haplotype and ischaemic stroke in a Greek population[J]. Eur J Neurol. 2007,14(7):745-749.
[27]Staton JM, Sayer MS, Hankey GJ, et al. Association between phosphodiesterase 4D gene and ischaemic stroke[J]. J Neurol Neurosurg Psychiatry.2006,77(9):1067-1069.
[28]Song Q, Cole JW, O'Connell JR, et al. Phosphodiesterase 4D polymorphisms and the risk of cerebral infarction in a biracial population:the Stroke Prevention in Young Women Study[J]. Hum Mol Genet.2006,15(16):2468-2478.
[29]Zee RY, Brophy VH, Cheng S, et al. Polymorphisms of the phosphodiesterase 4D, cAMP-specific (PDE4D) gene and risk of ischemic stroke:a prospective, nested case-control evaluation[J]. Stroke.2006,37(8):2012-2017.
[30]Brophy VH, Ro SK, Rhees BK, et al. Association of phosphodiesterase 4D polymorphisms with ischemic stroke in a US population stratified by hypertension status[J]. Stroke.2006,37(6):1385-1390.
[31]Nilsson-Ardnor S, Wiklund PG, Lindgren P, et al. Linkage of ischemic stroke to the PDE4D region on 5q in a Swedish population[J]. Stroke.2005,36(8): 1666-1671.
[32]Staton JM, Sayer MS, Hankey GJ, et al. Association between phosphodiesterase 4D gene and ischaemic stroke[J]. Journal of neurology, neurosurgery, and psychiatry.2006,77(9):1067-1069.
[33]Helgadottir A, Manolescu A, Thorleifsson G, et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke[J]. Nat Genet.2004,36(3):233-239.
[34]Dixon RA, Diehl RE, Opas E, et al. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis[J]. Nature.1990, 343(6255):282-284.
[35]Shen CD, Zhang WL, Sun K, et al. Interaction of genetic risk factors confers higher risk for thrombotic stroke in male Chinese:a multicenter case-control study[J]. Ann Hum Genet.2007,71(Pt 5):620-629.
[36]Kaushal R, Pal P, Alwell K, et al. Association of ALOX5AP with ischemic stroke:a population-based case-control study[J]. Hum Genet.2007,121(5): 601-607.
[37]Zhang WL, Yang XM, Shi J, et al. Polymorphism of SG13S114T/A in the ALOX5AP gene and the risk for stroke in a large Chinese cohort[J]. Yi Chuan Xue Bao.2006,33(8):678-684.
[38]Kajimoto K, Shioji K, Ishida C, et al. Validation of the association between the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a Japanese population[J]. Circ J.2005,69(9):1029-1034.
[39]Helgadottir A, Gretarsdottir S, St Clair D, et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population[J]. Am J Hum Genet.2005,76(3):505-509.
[40]Zee RY, Cheng S, Hegener HH, et al. Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke:a nested case-control approach[J]. Stroke.2006,37(8): 2007-2011.
[41]Nilsson-Ardnor S, Janunger T, Wiklund PG, et al. Genome-wide linkage scan of common stroke in families from northern Sweden[J]. Stroke.2007,38(1): 34-40.
[42]Rosand J, Altshuler D. Human genome sequence variation and the search for genes influencing stroke[J]. Stroke.2003,34(10):2512-2516.
[43]Woo D, Kaushal R, Chakraborty R, et al. Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage [J]. Stroke.2005,36(9):1874-1879.
[44]Woo D, Sekar P, Chakraborty R, et al. Genetic epidemiology of intracerebral hemorrhage[J]. J Stroke Cerebrovasc Dis.2005,14(6):239-243.
[45]Kaushal R, Woo D, Pal P, et al. Subarachnoid hemorrhage:tests of association with apolipoprotein E and elastin genes[J]. BMC Med Genet.2007,8:49.
[46]Gould DB, Phalan FC, van Mil SE, et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke[J]. N Engl J Med.2006,354(14):1489-1496.
[47]Alberts MJ, Davis JP, Graffagnino C, et al. Endoglin gene polymorphism as a risk factor for sporadic intracerebral hemorrhage [J]. Ann Neurol.1997,41(5): 683-686.
[48]Catto AJ, Kohler HP, Bannan S, et al. Factor XIII Val 34 Leu:a novel association with primary intracerebral hemorrhage [J]. Stroke.1998,29(4): 813-816.
[49]Gemmati D, Serino ML, Ongaro A, et al. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu):a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases[J]. Am J Hematol. 2001,67(3):183-188.
[50]Slowik A, Turaj W, Dziedzic T, et al. DD genotype of ACE gene is a risk factor for intracerebral hemorrhage [J]. Neurology.2004,63(2):359-361.
[51]Nadel JA. Genetics reveals importance of platelet activating factor in asthma and possibly other inflammatory states[J]. J Clin Invest.1996,97(12): 2689-2690.
[52]Navarro-Nunez L, Lozano ML, Rivera J, et al. The association of the betal-tubulin Q43P polymorphism with intracerebral hemorrhage in men[J]. Haematologica.2007,92(4):513-518.
[53]Banerjee I, Gupta V, Ganesh S. Association of gene polymorphism with genetic susceptibility to stroke in Asian populations:A meta-analysis[J]. Journal of Human Genetics.2007,52(3):205-219.
[54]Xu X, Li J, Sheng W, et al. Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population[J]. Cerebrovasc Dis.2008,26(1):48-62.
[55]Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration[J]. Science.2005,308(5720):385-389.
[56]Herbert A, Gerry NP, McQueen MB, et al. A common genetic variant is associated with adult and childhood obesity[J]. Science.2006,312(5771): 279-283.
[57]Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity[J]. Science.2007,316(5826):889-894.
[58]Saxena R, Voight BF, Lyssenko V, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels [J]. Science.2007, 316(5829):1331-1336.
[59]Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants[J]. Science. 2007,316(5829):1341-1345.
[60]Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease[J]. N Engl J Med.2007,357(5):443-453.
[61]严卫丽.复杂疾病全基因组关联研究进展-研究设计和遗传标记[J].遗传.2008,30(4)：400-406.
[62]Matarin M, Brown WM, Scholz S, et al. A genome-wide genotyping study in patients with ischaemic stroke:initial analysis and data release[J]. Lancet Neurol. 2007,6(5):414-420.
[63]Kubo M, Hata J, Ninomiya T, et al. A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction [J]. Nat Genet.2007, 39(2):212-217.
[64]Cupples LA, Arruda HT, Benjamin EJ, et al. The Framingham Heart Study 100K SNP genome-wide association study resource:overview of 17 phenotype working group reports[J]. BMC Med Genet.2007,8 Suppl 1:S1.
[65]Larson MG, Atwood LD, Benjamin EJ, et al. Framingham Heart Study 100K project:genome-wide associations for cardiovascular disease outcomes[J]. BMC Med Genet.2007,8 Suppl 1:S5.
[66]McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease[J]. Science.2007, 316(5830):1488-1491.
[67]Simon-Sanchez J, Singleton A. Genome-wide association studies in neurological disorders[J]. Lancet Neurology.2008,7(11):1067-1072.
[68]Dorningues-Montanari S, Mendioroz M, del Rio-Espinola A, et al. Genetics of stroke:a review of recent advances[J]. Expert Review of Molecular Diagnostics. 2008,8(4):495-513.
[69]Huang Q, Liu YH, Yang QD, et al. Human serum paraoxonase gene polymorphisms, Q192R and L55M, are not associated with the risk of cerebral infarction in Chinese Han population[J]. Neurol Res.2006,28(5):549-554.
[70]Xia J, Yuan M, Xu HW, et al. Association between Val/Leu(247) polymorphism of apolipoprotein H and cerebral infarction in a Chinese population[J]. J Thromb Thrombolysis.2008.
[71]胡中扬,张乐,杨期东,等.ApoB基因多态性与长沙汉族人群脑出血的关系及其对血脂水平的影响[J].中南大学学报：医学版.2008,33(6)：494-499.
[72]夏健,杨期东,杨期明,等.载脂蛋白H基因7号外显子多态性与长沙地区汉族人脑卒中的相关性[J].中华神经科杂志.2003,36(4)：256-260.
[73]张乐,杨期东.载脂蛋白B基因多态性与动脉粥样硬化性疾病[J].国外医学：神经病学.神经外科学分册.2003,30(5)：450-453.
[74]张乐,杨期东,曾艺,等.载脂蛋白B基因C7673T突变与有家族聚集现象脑梗死的关系[J].中华神经科杂志.2005,38(12)：784-785.
[75]张乐,曾艺,杨期东,等.载脂蛋白B基因G11039A多态与脑血管病的关系研究[J].实用预防医学.2005,12(4)：807-810.
[76]张乐,曾艺,杨期东,等.载脂蛋白b基因3'-VNTR多态与长沙地区脑血管病的关系研究[J].实用预防医学.2005,12(1)：57-59.
[77]Zhang L, Yang QD, Zeng Y. Positive association of apolipoprotein B gene C7673T polymorphism with cerebral hemorrhage with family history [J]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi.2008,25(2):145-149.
[78]Xia J, Yang QD, Yang QM, et al. Apolipoprotein H gene polymorphisms and risk of primary cerebral hemorrhage in a Chinese population[J]. Cerebrovasc Dis. 2004,17(2-3):197-203.